# Chapter 58: Somatic Symptom Disorder

Here is the comprehensive academic chapter on the biological and neurological basis of Somatic Symptom Disorder, citing only from the provided research papers.

***

# Chapter 12: The Biological and Neurological Basis of Somatic Symptom Disorder

## Introduction

Somatic Symptom Disorder (SSD) represents a significant clinical and conceptual challenge at the interface of medicine and psychiatry (Lipowski, 1986; Sheehan, 2010). It is characterized by the presence of one or more distressing physical symptoms that result in significant disruption of daily life, accompanied by excessive and disproportionate thoughts, feelings, or behaviors related to these symptoms or associated health concerns (D’Souza & Hooten, 2019; Fritzsche, 2019). This diagnostic framework represents a paradigm shift from previous classifications, such as somatoform disorders, by de-emphasizing the necessity for symptoms to be "medically unexplained" and instead focusing on the patient's dysfunctional response to their somatic experience (D’Souza & Hooten, 2019; Yutzy, 2015; 沙堅白, 2011). Patients with SSD often experience their symptoms as profoundly real and distressing, leading to a pattern of high healthcare utilization that seldom alleviates their concerns (Sansone & Sansone, 2010; Martin, 2021). The impairment associated with SSD is comparable to that seen in major mood and anxiety disorders, highlighting its clinical severity (Pentin & Sperry, 2015; Pentin & Sperry, 2016).

The prevalence of SSD in the general adult population is estimated to be between 5% and 7%, with higher rates among females, older individuals, and those with lower socioeconomic status (Martin, 2021). The disorder is not merely an adult condition; it is also recognized in children and adolescents, where it can present with debilitating pain, fatigue, or gastrointestinal complaints, leading to significant academic and social impairment (Srivastava et al., 2019; Johnson, 2017; Peyre & Viorrain, 2018). The clinical presentation is heterogeneous, ranging from specific localized pain to nonspecific complaints like fatigue (Torales, 2018; Rauh & Rief, 2024). This heterogeneity, combined with the subjective nature of the complaints, often makes diagnosis difficult (Rasmussen & Avant, 1989; Karvonen et al., 2016).

Understanding the biological and neurological underpinnings of SSD is crucial for developing more effective treatments and reducing the stigma associated with the diagnosis. While the etiology is understood to be multifactorial, involving a complex interplay of biological, psychological, and social factors (Dragoș & Tănăsescu, 2009; Kozlowska et al., 2020), the specific neurobiological mechanisms are still being elucidated. Direct biological research into SSD is an emerging field, and a comprehensive understanding requires drawing inferences from related and frequently comorbid conditions. SSD shows substantial overlap and comorbidity with anxiety disorders, depressive disorders, and chronic pain and fatigue syndromes (Maier & Falkai, 1999; Hranov, 2007; Iacovides & Siamouli, 2008; Geng et al., 2018). For instance, over 75% of depressed patients complain of painful physical symptoms (L�pine & Briley, 2004), and the presence of anxiety is strongly associated with somatic complaints (Awasthi, 2021; Singh & Dubey, 2015). Conditions such as chronic fatigue syndrome (CFS), fibromyalgia, and irritable bowel syndrome—often considered functional somatic syndromes—share many features with SSD, including persistent physical symptoms and high rates of psychiatric comorbidity (Wessely, 2001; Barsky, 1999; Kanbara & Fukunaga, 2009).

This chapter will synthesize the current understanding of the biological basis of SSD by examining evidence from several interrelated domains. We will explore the roles of neurotransmitter systems, neuroendocrine pathways such as the hypothalamic-pituitary-adrenal (HPA) axis, and neuro-immune interactions. We will review findings related to brain structure and function, drawing parallels from neuroimaging studies of comorbid disorders. Furthermore, we will discuss genetic and developmental factors that may confer vulnerability to SSD. Finally, we will consider how this biological understanding informs treatment mechanisms and shapes future research directions. By integrating these perspectives, we aim to construct a coherent biopsychosocial model of SSD that acknowledges the reality of the patient's suffering while grounding it in discernible neurobiological processes (Dragoș & Tănăsescu, 2009; Iacovides & Siamouli, 2008).

## Neurobiological Systems

The manifestation of Somatic Symptom Disorder is increasingly understood not as a purely psychological phenomenon, but as a complex disorder of brain-body regulation involving interconnected neurobiological systems (Kozlowska et al., 2020). Dysregulation within neurotransmitter, neuroendocrine, and neuro-immune systems appears to be central to the pathophysiology of SSD, contributing to heightened symptom perception, affective distress, and the perpetuation of the disorder (Schneiderman et al., 2004; Kuman, 2018). Given the high comorbidity between SSD and disorders of mood and anxiety (Maier & Falkai, 1999; Hranov, 2007), examining the biological systems implicated in these conditions provides crucial insights into the potential mechanisms of SSD.

### Neurotransmitter Systems and Neuropharmacology

While direct evidence from the provided literature on neurotransmitter function specifically in SSD is limited, the strong and frequent co-occurrence of SSD with depression and anxiety points toward shared neurobiological substrates (Iacovides & Siamouli, 2008; Maier & Falkai, 1999; Hranov, 2007). The monoamine neurotransmitter systems—serotonin, norepinephrine, and dopamine—are heavily implicated in mood and anxiety regulation and are therefore prime candidates for involvement in SSD (Fiar et al., 2012; Goldstein & Potter, 2004).

**Serotonin (5-HT):** The serotonergic system is deeply involved in regulating mood, sleep, appetite, and pain perception, all of which are frequently disturbed in SSD (Geng et al., 2018; Moret et al., 2008). The efficacy of selective serotonin reuptake inhibitors (SSRIs) in treating depression and anxiety disorders, which often present with somatic symptoms, supports this link (Falk et al., 2023; Montgomery et al., 1993). For example, a case report noted that escitalopram, an SSRI, successfully treated both major depressive disorder (MDD) and the somatic symptoms of polycystic ovary syndrome (Blay, 2011). This suggests that serotonergic modulation can impact both psychological distress and physical symptom presentation. Furthermore, serotonin syndrome, a state of excessive serotonergic activity, can manifest with a triad of mental status changes, autonomic dysfunction, and neuromuscular abnormalities, illustrating the profound influence of serotonin on both central and peripheral bodily functions (Bostankolu et al., 2014; Apelland et al., 1999). It is hypothesized that dysregulation in central serotonergic pathways may contribute to the affective components of SSD (e.g., health-related anxiety) and also to altered processing of bodily sensations, a phenomenon known as somatosensory amplification (Barsky, 1979; Dragoș & Tănăsescu, 2009). The involvement of serotonin in both mood and pain modulation provides a strong rationale for its role in SSD, where pain is a common presenting complaint (L�pine & Briley, 2004; Murakami & Matsuno, 2010).

**Norepinephrine (NE):** The noradrenergic system is central to the body's arousal and "fight-or-flight" stress response (Schneiderman et al., 2004). In anxiety disorders, this system is often hyperactive, leading to physical symptoms such as palpitations, sweating, and tremor (Munir & Takov, 2021; Ali et al., 2018). These are precisely the types of autonomic arousal symptoms frequently reported by individuals with SSD (D’Souza & Hooten, 2019). The efficacy of serotonin-norepinephrine reuptake inhibitors (SNRIs) in treating both depression and chronic pain conditions further implicates norepinephrine in the pathophysiology of somatic distress (Falk et al., 2023; Murakami & Matsuno, 2010). In SSD, a state of chronic hyperarousal may lower the threshold for perceiving benign bodily sensations as threatening, contributing to a vicious cycle of worry and physical symptoms (Kozlowska et al., 2020; Barsky, 1986).

**Dopamine (DA):** Dopamine is critical for motivation, reward, and pleasure (anhedonia, a core symptom of depression, is linked to dopaminergic dysfunction) (Fiar et al., 2012; Bhowmik et al., 2012). While less directly studied in the context of somatic symptoms, dopamine pathways interact extensively with serotonin and norepinephrine systems (Dervaux, 2013). In SSD, the loss of interest and profound fatigue could be related to disruptions in dopaminergic circuits that govern motivation and energy (Lam & Lam, 2018; Fava, 2003). Antipsychotic medications, which primarily act on dopamine receptors, are sometimes used in severe, treatment-resistant cases, particularly when psychotic features are present or for augmentation (Schultz et al., 2007; Moore et al., 1992), though their role in core SSD is not well-established.

**Gamma-Aminobutyric Acid (GABA):** GABA is the primary inhibitory neurotransmitter in the central nervous system, and its function is crucial for dampening neuronal excitability (Batinić et al., 2017). Dysfunction in the GABAergic system is a cornerstone of the neurobiology of anxiety disorders (Yarlagadda et al., 2007). Benzodiazepines, which enhance GABAergic transmission, are effective in acutely reducing anxiety and its somatic manifestations (Bismuth et al., 1980; Dugue & Neugroschl, 2002). This suggests that a state of GABAergic deficit or hypofunction could contribute to the hypervigilance, muscle tension, and restlessness seen in SSD (Munir & Takov, 2021; Mandos et al., 2009). However, the high potential for dependence limits the long-term use of benzodiazepines in a chronic condition like SSD (Schweizer & Rickels, 1996).

### Neuroendocrine Systems: The Stress Response

Chronic stress is a well-established risk factor for both the onset and exacerbation of physical and mental disorders, including SSD (Schneiderman et al., 2004; Parker & Manicavasagar, 2005; Kozlowska et al., 2020). The body’s primary stress response system is the hypothalamic-pituitary-adrenal (HPA) axis, which culminates in the release of cortisol (Stratakis et al., 1995; Schneiderman et al., 2004). While acute activation of the HPA axis is adaptive, chronic or dysregulated activation, often seen in response to prolonged psychosocial stress, can become pathogenic (Hellhammer & Wade, 1993; Parker & Manicavasagar, 2005; Wiegant, 1991).

Prolonged stress and elevated cortisol levels have been linked to a range of health problems, including depression, anxiety, and immune dysfunction (Kiecolt‐Glaser et al., 2020; Schneiderman et al., 2004). In the context of SSD, a dysregulated HPA axis could contribute to symptoms in several ways. First, chronic hypercortisolism, as seen in some forms of depression, can have widespread effects on the body, potentially generating or exacerbating physical symptoms like fatigue and pain (Juruena, 2012; Khare, 2021). Studies in chronic fatigue syndrome (CFS), a condition with significant symptomatic overlap with SSD, have pointed to HPA axis dysfunction, although findings have been inconsistent, with some suggesting hypocortisolism (Busse, 2007; Sharpe, 2010). This suggests that the nature of HPA axis dysregulation may be complex, possibly involving altered receptor sensitivity or rhythmic disruption rather than simple hyper- or hypo-secretion (Juruena, 2012; Wirz‐Justice, 1986).

Furthermore, early life adversity and trauma, which are significant risk factors for SSD (Martin, 2021; Ford, 1997), are known to have lasting effects on the programming of the HPA axis, leading to long-term vulnerability to stress-related disorders (Ferrara, 2014; Miller, 2004). This altered stress reactivity may mean that individuals with a history of trauma respond to minor daily stressors with an exaggerated physiological response, perpetuating a cycle of somatic distress and psychological worry (Kozlowska et al., 2020; Pennebaker, 1994). Hormonal fluctuations associated with the reproductive cycle in women, such as those occurring premenstrually or during the menopausal transition, may also represent periods of vulnerability, potentially interacting with the stress system to trigger or worsen somatic and affective symptoms (Fiebai et al., 2019; Duval et al., 2010; Korzekwa & Steiner, 1997).

### Neuro-Immune Interactions

The immune system is intricately linked with the central nervous and endocrine systems, and this "neuro-immune" network is profoundly influenced by psychological stress (Schneiderman et al., 2004; Khanam, 2017). Chronic stress and depression are associated with a state of low-grade systemic inflammation, characterized by elevated levels of pro-inflammatory cytokines (Kiecolt‐Glaser et al., 2020; Riba & Grassi, 2008). These cytokines can, in turn, induce "sickness behaviors," which include fatigue, malaise, pain, anhedonia, and social withdrawal—symptoms that overlap almost perfectly with those of SSD and depression (Yennurajalingam & Bruera, 2021; Geng et al., 2018).

This pathway offers a compelling biological model for many of the core symptoms of SSD. It is plausible that in vulnerable individuals, psychosocial stress triggers a persistent inflammatory response that directly generates somatic symptoms like fatigue and diffuse pain (Haffner‐Luntzer, 2025; Meade & Garvey, 2022). This hypothesis is central to research in related functional somatic syndromes. For example, CFS is often hypothesized to have an immunological or post-viral etiology, where an initial infection triggers a prolonged and dysregulated immune response (Sharpe, 2010; Wessely, 2001; Kawa, 1992). Similarly, conditions like fibromyalgia and irritable bowel syndrome are increasingly linked to neuro-inflammatory processes (Vergauwen, 2024; Hauser et al., 2011).

Therefore, in SSD, psychological distress may not just be a reaction to physical symptoms but a driver of the underlying pathophysiology via neuro-immune pathways (Kozlowska et al., 2020). The patient's excessive worry and focus on their symptoms could act as a chronic stressor, perpetuating HPA axis dysregulation and maintaining a pro-inflammatory state, which in turn feeds back to generate more somatic symptoms (Kiecolt‐Glaser et al., 2020). This model helps to bridge the gap between mind and body, suggesting that the psychological and biological components of SSD are not separate but are mechanistically intertwined in a self-sustaining loop (Dragoș & Tănăsescu, 2009).

## Genetic and Molecular Basis

The development of Somatic Symptom Disorder is widely considered to be the result of a complex interplay between genetic predispositions and environmental influences (Martin, 2021; Stahl, 2002). While the provided literature does not contain specific molecular genetic studies on SSD, a strong case for a heritable component can be built upon the established genetic links to highly comorbid psychiatric disorders and personality traits, as well as the profound impact of environmental factors on gene expression.

### Heritability and Genetic Predisposition

Family, twin, and adoption studies have consistently demonstrated a strong genetic influence in the etiology of both depressive and anxiety disorders (Watts & Markham, 2005; Maier & Falkai, 1999). Given that SSD frequently co-occurs with these conditions—to the extent that they are often considered part of the same spectrum of distress—it is highly probable that they share common genetic vulnerabilities (Hranov, 2007; Tollefson et al., 1993; Iacovides & Siamouli, 2008). This shared genetic diathesis may predispose individuals to a general susceptibility to mental distress, which can manifest as predominantly emotional symptoms (e.g., depression, anxiety) or predominantly somatic symptoms, depending on other biological and environmental factors (Wakefield & Schmitz, 2014; Korff & Simon, 1996).

Personality traits, which are themselves heritable, also play a significant role. Specifically, the trait of neuroticism—a tendency to experience negative emotions such as anxiety, anger, and sadness—is a robust predictor for the development of both mood and anxiety disorders, as well as somatoform complaints (Jeronimus, 2015; Hand, 1995). Individuals with an anxious worrying temperament, who are sensitive to minor changes and tend to worry excessively, may be genetically predisposed to hypervigilance towards bodily sensations, a core cognitive feature of SSD (Parker & Manicavasagar, 2005; Pennebaker, 1994). Therefore, the genetic risk for SSD may not be for the disorder itself, but for underlying traits that shape how an individual perceives, interprets, and responds to both internal bodily states and external stressors (Barsky, 1979).

### Gene-Environment Interactions

The "two-hit" or "multiple-hit" model, which posits that a genetic predisposition requires an environmental trigger to manifest as a disorder, is highly relevant to SSD (Arnold, 1999; Stahl, 2002). A crucial environmental factor highlighted across the literature is exposure to early life adversity, including childhood trauma, abuse, or neglect (Martin, 2021; Ferrara, 2014; Seifert, 2014; Ford, 1997). Such experiences are potent risk factors for nearly all major psychiatric conditions, including depression, anxiety, and substance use disorders, and are strongly associated with the development of somatic symptoms later in life (Pennebaker, 1994; Golding, 1999).

This suggests a classic gene-environment interaction, where an individual's genetic makeup modulates their sensitivity to stressful life events (Goodyer et al., 2000; Watts & Markham, 2005). An individual with a high genetic loading for neuroticism or affective instability who experiences significant childhood trauma may be at a substantially elevated risk for developing SSD in adulthood, particularly following a subsequent stressor (Lloyd, 1980; Roy, 1996). The traumatic experience may "program" the individual's stress-response systems to be hyperreactive, and this biological vulnerability, when combined with a later life event, may precipitate a cascade of somatic and psychological symptoms (Schneiderman et al., 2004; Kozlowska et al., 2020).

### Molecular and Epigenetic Mechanisms

While specific candidate genes for SSD are not identified in the available sources, we can hypothesize about the molecular pathways involved based on related conditions. The neurobiological systems discussed previously—monoaminergic neurotransmission, the HPA axis, and the immune system—are all under genetic control. Polymorphisms in genes related to serotonin transporters, dopamine receptors, or glucocorticoid receptors could influence an individual's susceptibility to stress and affective dysregulation, thereby increasing risk for SSD (Arbuck, 2022; Juruena, 2012).

Epigenetics offers a powerful molecular mechanism for explaining how early environmental experiences can induce lasting biological changes. Experiences like childhood abuse can lead to long-term alterations in gene expression through mechanisms such as DNA methylation, without changing the DNA sequence itself (Ferrara, 2014; Wolkowitz, 2018). For example, early life stress has been shown to alter the methylation of the glucocorticoid receptor gene, leading to persistent HPA axis dysregulation into adulthood (Juruena, 2012). Such epigenetic "memories" of trauma could create a state of biological vulnerability, predisposing an individual to an exaggerated stress response and subsequent somatic symptom development when faced with later adversities (Wolkowitz, 2018; Haffner‐Luntzer, 2025).

Another area of molecular investigation relevant to SSD is the concept of accelerated biological aging in serious mental disorders (Bersani et al., 2019; Wolkowitz, 2018). Chronic stress and depression have been linked to markers of cellular aging, such as telomere shortening and mitochondrial dysfunction (Wolkowitz, 2018). These processes are driven by factors like oxidative stress and inflammation, which are also implicated in the pathophysiology of chronic pain and fatigue (Meade & Garvey, 2022). It is plausible that the chronic psychological and physiological stress inherent in SSD could contribute to a similar process of accelerated aging at a molecular level, perpetuating a cycle of physical decline and somatic distress. This framework aligns with the observation that SSD is associated with significant physical disability and poor health outcomes over the long term (Pentin & Sperry, 2015; Ruttley et al., 2014).

In summary, the genetic and molecular basis of SSD is likely complex and polygenic, involving inherited vulnerabilities in personality and stress-response systems. These vulnerabilities interact with environmental factors, particularly early life adversity, which can induce lasting epigenetic changes. These processes converge to create a diathesis that, when activated by later stressors, manifests as the clinical syndrome of SSD.

## Brain Structure and Function

While the available literature does not provide direct neuroimaging studies specifically targeting Somatic Symptom Disorder, a robust understanding of the implicated neural architecture can be synthesized from research on overlapping and comorbid conditions, particularly chronic pain, chronic fatigue, anxiety, and depression (Spence, 2006; Johnston & Huckins, 2022). This approach suggests that SSD involves dysfunction within a network of brain regions responsible for interoception, emotional regulation, cognitive appraisal, and sensory processing.

### Neuroimaging and Neuroanatomical Findings

Functional neuroimaging studies in related disorders provide a window into the potential neural substrates of SSD. The clinical picture of SSD, characterized by a heightened focus on bodily sensations, catastrophic interpretation of these sensations, and significant emotional distress, points to dysfunction in several key brain circuits (Yutzy, 2015; D’Souza & Hooten, 2019; Fritzsche, 2019).

**1. Salience and Interoceptive Networks:** The insula and anterior cingulate cortex (ACC) are central hubs of the salience network, which is responsible for detecting and orienting attention toward relevant internal and external stimuli. These regions are also critical for interoception—the sense of the physiological condition of the body (Kozlowska et al., 2020). In patients with SSD, it is hypothesized that these networks are hyperactive, leading to an amplified perception of normal bodily sensations (somatosensory amplification) and a tendency to interpret them as salient and threatening (Barsky, 1979; Dragoș & Tănăsescu, 2009). This aligns with findings from studies on medically unexplained symptoms and functional somatic syndromes, which suggest that a common latent phenomenon of "bodily distress" may be underpinned by such altered central processing (Guthrie & Nayak, 2012). The experience of chronic pain, a frequent symptom in SSD, is also associated with changes in these brain regions, reflecting a state of central sensitization where the nervous system is in a persistent state of high reactivity (Treede, 2012; Murakami & Matsuno, 2010).

**2. Emotional Regulation and Threat Appraisal Networks:** The amygdala, prefrontal cortex (PFC), and hippocampus form a core circuit for emotional processing and regulation (Chen & Gong, 2021). The amygdala is crucial for threat detection, while the PFC exerts top-down control to modulate emotional responses (Fiar et al., 2012). In anxiety and depressive disorders, this circuit is often dysregulated, with amygdala hyperactivity and diminished PFC control (Hranov, 2007; Drevets, 2001). Given the high comorbidity, a similar pattern is likely present in SSD (Maier & Falkai, 1999). This imbalance could explain the excessive worry, fear of illness, and catastrophic thinking that are hallmarks of the disorder (Yutzy, 2015; D’Souza & Hooten, 2019). The hippocampus, critical for memory and context, may also be involved. Chronic stress and depression are associated with reduced hippocampal volume, which could impair the ability to contextualize bodily sensations appropriately, leading to overgeneralization of fear (Wolkowitz, 2018; Kumar et al., 1998; Novati, 2012).

**3. Executive Control and Motor Networks:** Some presentations of SSD, particularly conversion disorder (functional neurological symptom disorder), involve profound motor or sensory deficits, such as paralysis or blindness, without a corresponding neurological lesion (Ozdemir & Sahni, 2019; Hafeza et al., 2020). Neuroimaging studies in these conditions suggest dysfunction in frontal-striatal circuits involved in action planning and inhibition (Spence, 2006). It is hypothesized that in conversion disorder, top-down inhibitory signals from the PFC may suppress motor or sensory processing in a way that generates the functional deficit, reflecting an unconscious "conversion" of psychological conflict into a physical symptom (Mut, E. A., Pălădoiu, & Stănescu, 2021; 오덕원, 1997). The caudate nuclei, part of the basal ganglia, have been implicated in a variety of syndromes with somatic symptoms, including body dysmorphic disorder and somatization, suggesting a role for these motor-related structures in the generation of unexplained physical experiences (Spence, 2006).

### Functional Connectivity

Modern neuroscience increasingly emphasizes the importance of functional connectivity—the synchronized activity between distant brain regions—rather than the activity of isolated areas. In the context of SSD, it is likely that the disorder arises from aberrant connectivity within and between the networks described above. For example, pathologically increased connectivity between the salience/interoceptive network (insula, ACC) and the emotional regulation network (amygdala) could lead to a state where normal bodily sensations are immediately and intensely imbued with negative emotion and threat value (Kozlowska et al., 2020). Simultaneously, reduced connectivity between the PFC and the amygdala would impair the ability to down-regulate this fear response, trapping the individual in a cycle of anxiety and symptom monitoring (Fiar et al., 2012).

This model of altered network dynamics helps explain the persistence of symptoms in SSD. The brain effectively becomes "stuck" in a pathological mode of processing interoceptive information. This aligns with the clinical observation that reassurance from physicians is often only transiently effective; the underlying neural pattern of threat appraisal remains unchanged (Yutzy, 2015; Sansone & Sansone, 2010).

Furthermore, the profound fatigue reported in SSD and related syndromes like CFS may also have a basis in altered brain function and connectivity (Sharpe, 2010; Wessely, 2001). Studies in CFS have suggested altered brain function and reduced hypothalamic-pituitary-adrenal axis responsiveness (Spence, 2006). The subjective sense of effort and exhaustion may stem from inefficient processing within frontal and motor circuits, requiring greater neural resources to perform even minimal tasks (Roelcke, 2001; Paulig, 2006). This central component of fatigue is distinct from peripheral muscle weakness and highlights the brain's critical role in generating the somatic experience of the disorder (Fava, 2003; Geng et al., 2018).

In summary, while direct structural lesions are absent by definition in SSD, the disorder is associated with profound functional changes in the brain. A neurobiological model of SSD posits hyperactivity in salience and interoceptive networks, coupled with deficient top-down regulation from prefrontal control regions. This leads to an amplified perception of bodily signals, which are then catastrophically misinterpreted through dysregulated emotion and appraisal circuits. This altered brain function, likely shaped by genetic predispositions and life experiences, forms the core neuropathophysiology of Somatic Symptom Disorder.

## Developmental Neurobiology

The emergence of Somatic Symptom Disorder is best understood through a developmental lens, which considers how early life experiences, critical periods of neurodevelopment, and maturational processes contribute to an individual's vulnerability (Zauner, 1978; Martin, 2021). The disorder often has its roots in childhood and adolescence, with onset typically occurring before the age of 30 (Rasmussen & Avant, 1989; Srivastava et al., 2019). This timing suggests that the neurobiological systems underpinning SSD are shaped by developmental trajectories that can be perturbed by adverse experiences.

### Critical Periods and Early Life Adversity

The developing brain is exquisitely sensitive to its environment, and early life represents a critical period for the calibration of stress-response systems (Stratakis et al., 1995). Exposure to significant adversity during childhood—such as physical, emotional, or sexual abuse; neglect; or profound family dysfunction—is a powerful and consistently identified risk factor for a wide range of adult psychiatric disorders, including SSD (Ferrara, 2014; Seifert, 2014; Ford, 1997; Golding, 1999). Such traumatic experiences can have lasting neurobiological consequences, effectively "programming" the brain for a lifetime of altered stress reactivity (Miller, 2004; Pennebaker & Chung, 2006).

One of the primary mechanisms for this programming is the enduring alteration of the HPA axis (Stratakis et al., 1995). Chronic early life stress can lead to long-term changes in the regulation of cortisol, the body's main stress hormone, resulting in either a hyper- or hypo-responsive HPA axis in adulthood (Juruena, 2012; Schneiderman et al., 2004). This dysregulation means that an individual may respond to later life stressors with an inappropriate or exaggerated physiological response, which can manifest as somatic symptoms like pain, fatigue, or autonomic arousal (Kozlowska et al., 2020; Wiegant, 1991). This biological sensitization may explain why many individuals with SSD report that their symptoms began or worsened following a stressful life event in adulthood; their systems were already primed for dysregulation by earlier experiences (Stevenson, 1969; Lloyd, 1980).

Adolescence represents another critical developmental window (Zauner, 1978). The significant hormonal, physical, and social changes of this period place considerable stress on the developing individual (Wa, 1985). This is also a time of significant brain maturation, particularly in the prefrontal cortex, which is responsible for executive functions and emotional regulation (Hechtman, 1991). The onset of SSD or its precursors during adolescence may reflect the interaction between this ongoing neurodevelopment and increasing psychosocial demands (Srivastava et al., 2019; Peyre & Viorrain, 2018). For example, social phobia, which has a typical onset in the mid-teens, involves a profound fear of negative evaluation that is often accompanied by somatic symptoms like blushing, sweating, and trembling (Schneier et al., 2014; Westenberg, 1998). This demonstrates how developmental social pressures can manifest through bodily symptoms.

### Learning and Social Modeling

Beyond direct neurobiological programming, developmental experiences shape the cognitive and behavioral patterns that contribute to SSD. Children learn how to interpret and respond to bodily sensations by observing family members (Benjamin & Eminson, 1992). Growing up in a family where physical symptoms are a primary means of communicating distress or receiving care can establish a learned pattern of "illness behavior" (Ford, 1992). A child may learn, unconsciously, that expressing somatic complaints is a more acceptable or effective way to elicit attention and support than expressing emotional needs directly (Benjamin & Eminson, 1992; Steinberg, 1988). This learned behavior, when carried into adulthood, can form the foundation for the excessive focus on symptoms and help-seeking characteristic of SSD (Pentin & Sperry, 2015).

Furthermore, a history of genuine physical illness in childhood can create a vulnerability to SSD (Unknown, 1993). A child who has a chronic health condition may develop a heightened awareness of their body and a lower threshold for interpreting sensations as signs of illness (Iacovides & Siamouli, 2008). This can lead to a pattern of health anxiety that persists even after the original illness has resolved, contributing to the development of Illness Anxiety Disorder or SSD (Noyes, 2014; Rathbone & Prescott, 2019).

### Lifespan Considerations

While SSD often begins in early life, its presentation can evolve across the lifespan. In older adults, the clinical picture is often complicated by the presence of multiple chronic medical conditions, cognitive changes, and the cumulative losses associated with aging (Fiske et al., 2009; Topinková, 2008; Kral, 1973). Depression in the elderly, for example, is frequently characterized by a predominance of somatic complaints such as pain, fatigue, and insomnia, rather than overt sadness (Fiske et al., 2009; Kivelä & Pahkala, 1988; Taylor, 2014). This "somatic mask" can make it difficult to distinguish SSD from late-life depression or the symptoms of physical illness (Müller‐Spahn & Hock, 1994; Fiske et al., 2009). The increased prevalence of physical health problems in older age provides more "material" for health-related anxieties and somatic preoccupation (Morgan et al., 1997). At the same time, age-related neurobiological changes, such as vascular brain disease, can themselves be risk factors for depression and its somatic manifestations (Luijendijk, 2010; Alexopoulos, 2001). This complex interplay makes the diagnosis and management of SSD in the elderly particularly challenging, requiring a careful disentanglement of biological aging, physical disease, and psychopathology (Cho, 2005; Wertheimer, 2001).

In conclusion, the neurobiology of SSD is fundamentally developmental. Early life adversity can create lasting biological vulnerabilities in stress-response systems. Concurrently, learned behaviors and cognitive schemas regarding illness and symptoms are established in childhood and adolescence. These developmental pathways converge, creating a predisposition that may be activated by stressors later in life, leading to the clinical manifestation of Somatic Symptom Disorder.

## Treatment Mechanisms

The treatment of Somatic Symptom Disorder requires an integrated biopsychosocial approach, as the disorder's mechanisms are rooted in a complex interplay of biological vulnerabilities, psychological processes, and social factors (Dragoș & Tănăsescu, 2009; Kozlowska et al., 2020). Effective interventions target these multiple levels, aiming to modulate underlying neurobiological dysregulation while simultaneously restructuring maladaptive thoughts and behaviors. The biological basis of these treatments can be understood by examining their effects on the neurotransmitter, neuroendocrine, and neural circuit dysfunctions implicated in SSD.

### Neuropharmacological Interventions

Although no medications are specifically approved for SSD itself, pharmacotherapy is frequently used to target core symptoms and comorbid conditions, primarily depression and anxiety (Fritzsche, 2019; Srivastava et al., 2019). The neurobiological rationale for this approach stems from the substantial overlap in the pathophysiology of these disorders.

**Antidepressants:** Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) are considered first-line treatments (Falk et al., 2023; Montgomery et al., 1993). Their mechanism of action involves increasing the synaptic availability of serotonin and/or norepinephrine (Moret et al., 2008). This modulation is thought to have a dual effect relevant to SSD. First, it directly addresses the comorbid depressive and anxious symptoms that fuel health worries and amplify distress (Hranov, 2007; Tollefson et al., 1993). By alleviating anxiety and improving mood, these agents can reduce the emotional suffering component of the disorder (Goldstein & Potter, 2004). Second, these neurotransmitter systems are integral to the descending pain modulation pathways in the central nervous system (Murakami & Matsuno, 2010; L�pine & Briley, 2004). By enhancing serotonergic and noradrenergic signaling, antidepressants can exert a direct analgesic effect, reducing the perceived intensity of pain, which is one of the most common and disabling somatic symptoms (Bair et al., 2003; Treede, 2012). The efficacy of these drugs for painful physical symptoms in depression supports this mechanism (L�pine & Briley, 2004). Tricyclic antidepressants (TCAs) also have proven efficacy, particularly for neuropathic pain, but their use is often limited by a less favorable side-effect profile, including anticholinergic and cardiotoxic effects (Montgomery et al., 1993; Pitchot et al., 2007).

**Anxiolytics and Other Agents:** For acute anxiety, benzodiazepines may be used for short-term relief by enhancing GABAergic inhibition (Dugue & Neugroschl, 2002; Bismuth et al., 1980). However, their long-term use is discouraged in chronic conditions like SSD due to risks of tolerance, dependence, and potential cognitive impairment (Schweizer & Rickels, 1996). In some cases, particularly when symptoms are severe or resistant to initial treatments, low-dose atypical antipsychotics may be considered as an augmentation strategy (Ali et al., 2018). Their mechanism, primarily involving dopamine and serotonin receptor modulation, may help in reducing overwhelming anxiety, and in cases with quasi-delusional health beliefs, may temper the intensity of these convictions (Lepping et al., 2015).

### Neurobiology of Psychosocial Interventions

Psychosocial treatments, particularly Cognitive Behavioral Therapy (CBT), are a cornerstone of management for SSD and have demonstrated efficacy in reducing symptom severity and improving function (Srivastava et al., 2019; Fritzsche, 2019). The biological impact of these therapies can be understood through the lens of neuroplasticity—the brain's ability to reorganize itself in response to experience.

**Cognitive Behavioral Therapy (CBT):** CBT for SSD focuses on identifying and modifying maladaptive thoughts (e.g., catastrophic interpretations of bodily sensations), beliefs, and behaviors (e.g., excessive symptom checking, avoidance of activity) (Srivastava et al., 2019; Fritzsche, 2019). From a neurobiological perspective, this cognitive restructuring process is believed to engage and strengthen top-down regulatory control from the prefrontal cortex (PFC) over limbic structures like the amygdala (Spence, 2006). By learning to reappraise bodily sensations as non-threatening, patients can reduce amygdala-driven fear and anxiety responses, thereby breaking the vicious cycle of symptom amplification (Kozlowska et al., 2020). The behavioral component of CBT, which often includes graded exposure to avoided activities and response prevention (i.e., reducing checking behaviors), helps to recalibrate the salience network. Through repeated experience, the brain learns that physical activity does not lead to catastrophic outcomes, leading to habituation and a reduction in the perceived threat value of somatic symptoms (Praško et al., 2010).

**Mind-Body and Relaxation-Based Therapies:** Interventions such as relaxation training, yoga, and mindfulness have also shown utility in managing somatic symptoms (Wahyuningsih et al., 2020; Lovas, 2015; Praško et al., 2010). These techniques are thought to work by directly modulating the autonomic nervous system (ANS). Practices like deep breathing and progressive muscle relaxation can shift the ANS from a state of sympathetic ("fight-or-flight") dominance to one of parasympathetic ("rest-and-digest") dominance (Wahyuningsih et al., 2020). This shift leads to physiological changes such as decreased heart rate, lower blood pressure, and reduced muscle tension, which can directly alleviate many of the physical symptoms of anxiety and hyperarousal (Viljoen et al., 2013). Over time, regular practice of these techniques may improve autonomic flexibility and dampen the chronic stress response, thereby reducing HPA axis activation and its downstream consequences (Kozlowska et al., 2020).

**Physical Activity and Exercise:** Graded exercise therapy is another key intervention, particularly for symptoms of fatigue and pain, as seen in related conditions like CFS and fibromyalgia (Vergauwen, 2024; Praško et al., 2010; Skinner, 2004). The biological mechanisms are multifactorial. Exercise has well-documented antidepressant and anxiolytic effects, which may be mediated by increases in monoamine neurotransmitters and the release of endogenous opioids (endorphins) (Smith & Blumenthal, 2015; Ekkekakis, 2014). Furthermore, regular physical activity can have anti-inflammatory effects, potentially counteracting the low-grade inflammation associated with chronic stress and depression (Silverman & Deuster, 2014). By gradually increasing physical capacity, exercise therapy also directly challenges patients' fears about physical exertion and helps reverse the deconditioning that often accompanies chronic illness and activity avoidance (Skinner, 2004). This process helps restore a sense of physical self-efficacy and control.

In conclusion, the treatment of SSD involves a multi-pronged approach that leverages both pharmacological and psychological interventions to modify the underlying neurobiological substrate. Pharmacotherapy primarily targets neurotransmitter imbalances to reduce affective distress and pain, while psychotherapies promote neuroplastic changes in brain circuits involved in appraisal, regulation, and attention, ultimately helping patients to develop a more adaptive relationship with their bodily experiences.

## Future Directions

The conceptualization of Somatic Symptom Disorder has evolved significantly, shifting the focus from the medical inexplicability of symptoms to the patient's psychological and behavioral response to them (D’Souza & Hooten, 2019; Yutzy, 2015). This evolution necessitates a corresponding shift in research priorities towards elucidating the specific biological and neurological mechanisms that underpin this dysfunctional brain-body interplay. While much of our current understanding is inferred from comorbid conditions (Maier & Falkai, 1999; Hranov, 2007), future research must focus directly on SSD to validate these hypotheses and develop more targeted and effective interventions.

A primary imperative is the need for dedicated neuroimaging research in well-characterized SSD populations. Longitudinal functional and structural MRI studies are required to move beyond cross-sectional associations and map the trajectory of brain changes in SSD. Such studies could clarify whether alterations in regions like the insula, anterior cingulate cortex, and amygdala are pre-existing vulnerability markers, consequences of the disorder, or dynamic state markers that fluctuate with symptom severity (Spence, 2006; Chen & Gong, 2021). Advanced techniques like resting-state functional connectivity could reveal the specific network-level dysfunctions—for example, aberrant coupling between salience, affective, and executive control networks—that may define the disorder (Kozlowska et al., 2020).

Genetic and epigenetic research specific to SSD is another critical frontier. While we hypothesize shared genetic liabilities with depression and anxiety (Watts & Markham, 2005), genome-wide association studies (GWAS) are needed to identify specific risk loci for somatic symptom presentation. A crucial avenue of investigation is the exploration of gene-environment interactions (Goodyer et al., 2000). Research should prospectively examine how genetic polymorphisms, for instance in the serotonin transporter gene or genes regulating the HPA axis, interact with early life adversity to predict the development of SSD in adulthood (Ferrara, 2014; Wolkowitz, 2018). Epigenetic studies, examining modifications like DNA methylation, could provide a molecular link explaining how early trauma becomes biologically embedded to create long-term vulnerability (Ferrara, 2014).

Further investigation into neuro-immune and neuroendocrine pathways is essential. This includes more detailed profiling of inflammatory markers (e.g., cytokines) and HPA axis function (e.g., diurnal cortisol rhythms, dexamethasone suppression tests) in SSD patients compared to healthy controls and other psychiatric groups (Kiecolt‐Glaser et al., 2020; Schneiderman et al., 2004). Such research could help determine whether specific inflammatory or endocrine signatures characterize SSD or define specific subtypes of the disorder (Busse, 2007). For example, it remains unclear whether the HPA axis dysfunction in SSD more closely resembles the hypercortisolism of melancholic depression or the hypocortisolism reported in some chronic fatigue and post-traumatic stress populations (Juruena, 2012). Understanding these profiles could lead to novel therapeutic targets, such as anti-inflammatory agents or glucocorticoid receptor modulators.

The field would also benefit from a deeper exploration of biological subtypes and heterogeneity within SSD. The current diagnostic category is broad, encompassing patients with single-symptom presentations (e.g., chronic pain) and those with polysymptomatic distress (D’Souza & Hooten, 2019; Fritzsche, 2019). It is unlikely that a single biological mechanism underlies this diversity. Future research should employ data-driven approaches, such as cluster analysis, to integrate clinical, cognitive, and biological data (e.g., neuroimaging, genetic, inflammatory markers) to identify distinct biotypes of SSD. Identifying such subtypes could revolutionize treatment by allowing for a personalized medicine approach, matching patients with interventions most likely to target their specific underlying pathophysiology (Stahl, 2002).

Translational research bridging basic neuroscience and clinical practice is also paramount. Animal models that capture aspects of SSD, such as those involving early life stress leading to visceral hypersensitivity or sickness behavior, can be invaluable for testing novel therapeutic compounds and understanding fundamental mechanisms (Kozlowska et al., 2020). For instance, models could help dissect the precise role of specific neurotransmitter systems or immune pathways in the generation of somatic symptoms, guiding the development of more targeted pharmacotherapies (Fiar et al., 2012).

Finally, the mechanisms of existing effective treatments need to be better understood from a biological perspective. Neuroimaging studies before and after a course of CBT or mindfulness-based therapy could reveal the specific changes in neural circuitry that correlate with clinical improvement. This would not only validate the neuroplastic effects of psychotherapy but could also identify biomarkers that predict treatment response (Srivastava et al., 2019). Similarly, understanding why some patients with SSD respond to antidepressants while others do not may lie in their underlying biological profiles, linking back to the need for research on biotypes.

In conclusion, the future of SSD research lies in a direct and rigorous investigation of its biological underpinnings. By moving beyond inference and employing modern neuroscience tools, the field can aim to demystify the disorder, identify objective biomarkers, and pave the way for novel, mechanism-based treatments that can more effectively alleviate the profound suffering of patients with Somatic Symptom Disorder.

## Conclusion

Somatic Symptom Disorder stands as a compelling example of the inextricable link between the mind and body, a clinical entity defined by genuine physical suffering that is amplified and maintained by psychological distress (Lipowski, 1986; Dragoș & Tănăsescu, 2009). This chapter has synthesized a neurobiological framework for SSD, constructed largely through inference from the extensive literature on comorbid and overlapping conditions such as anxiety, depression, chronic pain, and chronic fatigue (Maier & Falkai, 1999; Hranov, 2007; Wessely, 2001). While direct biological evidence for SSD is still in its relative infancy within the provided sources, a coherent and plausible model emerges, positioning the disorder not as a manifestation of a "weakness of character" but as a legitimate and complex disorder of brain-body regulation (Kozlowska et al., 2020).

The evidence points toward a multifactorial etiology where genetic predispositions and developmental experiences converge to shape an individual's neurobiological vulnerability. Inherited traits such as neuroticism, coupled with the lasting impact of early life adversity, appear to sensitize key regulatory systems (Jeronimus, 2015; Ferrara, 2014; Martin, 2021). Chief among these are the body's stress-response networks, particularly a dysregulated HPA axis, and an overactive sympathetic nervous system (Schneiderman et al., 2004; Kozlowska et al., 2020). This primed state of hyperarousal and altered stress reactivity provides the biological substrate upon which the disorder develops.

At the level of brain function, SSD can be conceptualized as a disorder of aberrant neural circuitry. It appears to involve hyperactivity in networks responsible for interoception and salience detection, such as the insula and anterior cingulate cortex, leading to an amplified perception of bodily sensations (Spence, 2006; Barsky, 1979). This heightened sensory input is then processed through dysregulated emotional and cognitive appraisal circuits, including a hyperreactive amygdala and insufficiently engaged prefrontal regulatory regions (Chen & Gong, 2021). The result is a catastrophic misinterpretation of benign or minor physical symptoms, which become imbued with a sense of threat and danger, locking the patient into a self-perpetuating cycle of fear, hypervigilance, and somatic distress (Fritzsche, 2019; Yutzy, 2015).

This neurobiological model is further supported by the mechanisms of effective treatments. Pharmacological interventions, such as SSRIs and SNRIs, likely work by modulating monoaminergic systems that are crucial for both mood and descending pain control (Moret et al., 2008; L�pine & Briley, 2004). Psychotherapies like CBT appear to induce neuroplastic changes, strengthening top-down prefrontal control over limbic fear circuits and recalibrating the brain's interpretation of interoceptive signals (Srivastava et al., 2019). Mind-body therapies and exercise contribute by directly modulating the autonomic nervous system and reducing the systemic effects of chronic stress, such as low-grade inflammation (Wahyuningsih et al., 2020; Silverman & Deuster, 2014).

In synthesizing this evidence, it becomes clear that the traditional mind-body dualism is an inadequate framework for understanding SSD (Lipowski, 1986). The "psychological" aspects of the disorder—the excessive thoughts, feelings, and behaviors—are not merely reactions to the physical symptoms; they are integral components of the neurobiological processes that generate and sustain them. Emotional distress can drive physiological changes through neuroendocrine and neuro-immune pathways, and these physiological changes, in turn, provide more sensory data to be amplified and misinterpreted by a sensitized brain (Kiecolt‐Glaser et al., 2020; Dragoș & Tănăsescu, 2009). Moving forward, a continued focus on these integrated biopsychosocial mechanisms will be essential for destigmatizing Somatic Symptom Disorder and developing more targeted, personalized, and effective treatments for the many individuals whose lives are profoundly impacted by it.

## References

1. Abad, A., Matesanz, C. M., Acosta, C. R. D., & López, C. M. (2022). Sleep apnoea and sleep disorders. Pathy's Principles and Practice of Geriatric Medicine. https://doi.org/10.1002/9781119484288.ch45
2. Abay, H., & Kaplan, S. (2019). Current Approaches in Premenstrual Syndrome Management. Bezmialem Science. https://doi.org/10.14235/bas.galenos.2018.2358
3. Abee, K. (2018). Het mechanisme hoe slaapdeprivatie obesitas induceerd.
4. Abildgaard, U. (1993). [Coma from cerebral and metabolic causes].. PubMed.
5. Abi‐Jaoude, E., Stall, N. M., & Rochon, P. A. (2018). Psychotropic drugs for the behavioural and psychological symptoms of dementia: no free ride. Canadian Medical Association Journal. https://doi.org/10.1503/cmaj.181486
6. Adams, J., & Kirkby, R. J. (2001). Exercise Dependence and Overtraining: The Physiological and Psychological Consequences of Excessive Exercise. Sports medicine, training, and rehabilitation/Sports medicine, training and rehabilitation. https://doi.org/10.1080/10578310210395
7. Adhikari, A., Karna, V., & Sangroula, D. (2024). Depression: Symptoms, Causes, and Effective Coping Strategies. The American journal of patient health info.. https://doi.org/10.69512/ajphi.v1i01.43
8. Agarwal, K., Yadav, A. K., Verma, P., & Kaur, B. (2021). DYSTHYMIA AND it’s HOMOEOPATHIC MANAGEMENT. Journal of Emerging Technologies and Innovative Research.
9. Ahemad, M., Ahmad, P. M. F., & Shafaat, M. (2018). Effect of Dalak (Massage) in the Management of Sahar (Insomnia). https://doi.org/10.37591/rrjoush.v5i2.130
10. Akram, A. S., Sarwar, R., Zafar, M. F., Umair, M., Ullah, I., & Nazir, A. (2023). First oral treatment zuranolone’s FDA approval and its impact on postpartum depression: a new hope – a correspondence. International Journal of Surgery Global Health. https://doi.org/10.1097/gh9.0000000000000345
11. Alanbagi, A. A., & Al-Zamily, R. H. (2019). The depression among cancer patients during chemotherapy and its relation to demographic and social data. International Journal of Research in Pharmaceutical Sciences.
12. Albuquerque, A. C. D., Silva, J. R. D., & Silva, J. (2015). The “roundabout Man” Trapped in the “roundabout City” – a Case Report of a Severe Obsessive Compulsive Disorder. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)32056-3
13. Alchieri, J. C., & Urquijo, S. (2022). Aspectos demenciais frontotemporais como desafios em processos periciais psicológicos. Revista Psicologia Jurídica Forense. https://doi.org/10.56492/issn.27647374.2022n1a1
14. Alexandre, S., Misery, L., Dutray, S., Chastaing, M., Consoli, S.-M., Audra, H., Bauer, D., Bertolus, S., Callot, V., Cardinaud, F., Corrin, E., Féton-Danou, N., Malet, R., Touboul, S., & Consoli, S. (2007). Functional Itch Disorder or Psychogenic Pruritus: Suggested Diagnosis Criteria From the French Psychodermatology Group. Acta Dermato Venereologica. https://doi.org/10.2340/00015555-0266
15. Alfarossi, O. L., & Hutasoit, H. B. K. (2020). Gejala Psikotik pada Pasien dengan Epilepsi Tidak Terkontrol. Jurnal Medula.
16. Ali, A. M. (2018). So, Antidepressant Drugs have Serious Adverse Effects, but what are the Alternatives?. Novel Approaches in Drug Designing & Development. https://doi.org/10.19080/napdd.2018.04.555636
17. Ali, N., Rasheed, A., Tariq, I., Abdullah, F., Sarwar, A., Atta, R., & Qammer, Z. (2018). Adjunct Use of Low Dose Risperidone Verses Adjunct Use of Clonazepam with an SSRI in Treatment of Moderate to Severe Anxiety States; A Comparative Study. National Journal of Health Sciences. https://doi.org/10.21089/njhs.32.0051
18. Alkan, A., Öztorun, H. S., Karcı, E., Ürün, Y., Tuncay, G., Yaşar, A., Çınar, E., Aras, S., Varlı, M., Utkan, G., Demirkazık, A., Akbulut, H., & Şenler, F. Ç. (2020). The Impact of Loneliness and Cancer Diagnosis on Cognitive Impairment in Geriatric Patients. Journal of Oncological Sciences. https://doi.org/10.37047/jos.2019-71889
19. Allen, R. P. (2016). Restless Legs Syndrome Effects on Quality of Life. CRC Press eBooks. https://doi.org/10.3109/9781420019575-18
20. Alloy, L. B., & Abramson, L. Y. (2010). Cyclothymic Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0249
21. Alonso-Fernández, F. (2009). Las cuatro dimensiones del enfermo depresivo. Salud Mental.
22. Altonbary, A. (2021). A Mental or Behavioural Post Traumatic Disorder.
23. Alvarenga, E. C., Oliveira, P. D. T. R. D., Souza, L. C. D., & Barroso, R. F. F. (2016). Como é o atendimento em Saúde Mental feito pelas Equipes de Saúde da Família do Pará. 12º Congresso Internacional da Rede Unida.
24. Amihăesei, I. C., & Cojocaru, E. (2014). Main neuroendocrine features, diagnosis and therapeutic possibilities in the chronic fatigue syndrome, an underdiagnosed entity.. PubMed.
25. Amores, F. B. C., Pérez, G. P. L., Torres, N. A. C., & Carpio, V. D. P. C. (2023). Sleep pattern impairment in nursing students according to NANDA. Medwave. https://doi.org/10.5867/medwave.2023.s1.uta111
26. Amorim, M. J., Maurício, J., & Brandão, D. (2019). WHEN THE DISEASE ARISES FROM THE TREATMENT: CORTICOSTEROID-INDUCED PSYCHOSIS A CASE REPORT AND BRIEF LITERATURE REVIEW. https://doi.org/10.26226/morressier.5d1a037b57558b317a140b63
27. Amron, S. B., Kandasami, G., Lee, C., Guo, S. L., & Tan, H. (2025). Making sense of ICD-11 diagnostic criteria of compulsive sexual behavioural disorder. Annals of the Academy of Medicine Singapore. https://doi.org/10.47102/annals-acadmedsg.2024266
28. An, T., Ra, Y., Han, C., Kim, H., Lee, K.-S., & Bae, H. (2015). Clinical Correlates of Subtype and Severity in Patients with Delirium. Journal of Korean Neuropsychiatric Association. https://doi.org/10.4306/jknpa.2015.54.4.489
29. Ananto, A. S., & Suryati, E. (2019). Ensefalopati Hipertensi pada Anak dengan Glomerulonefritis Akut Pasca Streptokokal.
30. Angst, J., Rufer, M., Fineberg, N., Ajdacic‐Gross, V., & Rössler, W. (2015). Zwangsstörungen vom 20.–50. Altersjahr: Prävalenz, Komorbidität und Remission. Praxis. https://doi.org/10.1024/1661-8157/a002205
31. Ansari, S., & Kang, T. K. (2019). Stress of Aged Elderly:A Review. Indian Journal of Health and Wellbeing.
32. Ara, I., Maqbool, M., & Zehravi, M. (2022). Psychic consequences of infertility on couples: A short commentary. Open Health. https://doi.org/10.1515/openhe-2022-0022
33. Arandjelovic, D., Misic, P., Serafimovic, S., & Petrovic, M. (2010). P01-366 - Psychiatric Syndromes and Disorders in Older Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70574-5
34. Arbuck, D. M. (2022). Neurotransmitter-based diagnosis and treatment: A hypothesis (Part 2). Current psychiatry. https://doi.org/10.12788/cp.0253
35. Ardiyani, I. D., & Muljohardjono, H. (2020). Intervensi untuk Mengurangi Stigma pada Penderita Skizofrenia. Jurnal Psikiatri Surabaya. https://doi.org/10.20473/jps.v8i1.14655
36. Argyriou, A. A., Anastopoulou, G. G., & Bruna, J. (2018). Inconclusive evidence to support the use of minimally-invasive radiofrequency denervation against chronic low back pain. Annals of Translational Medicine. https://doi.org/10.21037/atm.2018.01.23
37. Arikian, S. R., & Gorman, J. M. (2001). A Review of the Diagnosis, Pharmacologic Treatment, and Economic Aspects of Anxiety Disorders. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.v03n0302
38. Arnold, S. E. (1999). Schizophrenia. Humana Press eBooks. https://doi.org/10.1007/978-1-4612-1602-5_27
39. Arnáez, S. (2019). Vulnerabilidad cognitiva a la hipocondría: intrusiones, valoraciones y creencias disfuncionales/ cognitive vulnerability to hypochondriasis: intrusions, appraisals and dysfunctional beliefs.
40. Arredondo-Aldana, K., Mera-Posligua, M. J., & Alencastro, J. A. P. (2021). Trastorno Depresivo Persistente y Trastornos de Ansiedad Generalizada Proveniente de un Estrés Post Traumático Crónico: Presentación de un Caso Clínico. Revista Científica Arbitrada en Investigaciones de la Salud GESTAR. https://doi.org/10.46296/gt.v4i8edesp.0027
41. Arroyo, H., Klipstein, K., Ernst, C. L., & Finkel, J. H. (2016). Somatic Symptom and Related Disorders, Including Illness Anxiety, Factitious, Malingering, and Conversion Disorders. https://doi.org/10.1002/9781118654231.ch20
42. Asad, F., Jahangarad, S., & Dorgalaleh, A. (2023). Psychological complications among patients with congenital bleeding disorders. Blood Coagulation & Fibrinolysis. https://doi.org/10.1097/mbc.0000000000001191
43. Austin, D. S. (2015). Got Stress? You May Be Harming Your Brain. SSRN Electronic Journal.
44. Autor, S. (2002). CÁPSULAS PARA LA VIDA.- ANSIEDAD. Gaceta UNAM (2000-2009).
45. Awasthi, I. (2021). Association between Bodily Complaint and Anxiety. International Journal for Research in Applied Science and Engineering Technology. https://doi.org/10.22214/ijraset.2021.38354
46. Aziz, F., ZAHID, A., TASNEEM, W., & ANWAR, R. (2022). Impact of Shift Work on Health: A Review. Annals of King Edward Medical University. https://doi.org/10.21649/akemu.v9i2.4941
47. B.R, R., & N.K.C, E. (2019). A review on pain and its signals modulation by body. IP International Journal of Comprehensive and Advanced Pharmacology. https://doi.org/10.18231/j.ijcaap.2019.018
48. Bach, J. (2015). Unintentional Harm of Older Adults.
49. Bajlović, R. (2019). Zdravstvena njega bolesnika s anksioznim poremećajem.
50. Baldwin, D. S., & Tiwari, N. (2015). Anxiolytic and hypnotic drugs. CRC Press eBooks. https://doi.org/10.1201/b18821-14
51. Baldwin, D. S., Ajel, K., & Garner, M. (2008). Anxiety disorders. Medicine. https://doi.org/10.1016/j.mpmed.2008.05.002
52. Balhara, Y. P. S., Mohan, I., Sagar, R., & Chawla, J. (2006). Chronic mania: An unexpectidly long episode?. Indian Journal of Medical Sciences. https://doi.org/10.4103/0019-5359.25681
53. Bamalan, O. A., Alosaimi, N. M., Alfryyan, A. A., Aljubran, H. J., Alanazi, F. H., & Siddiqui, Z. I. (2023). Generalized Anxiety Disorder: A Review of Current Literature in Saudi Arabia. Psychology. https://doi.org/10.4236/psych.2023.141003
54. Barsky, A. J. (1979). Patients Who Amplify Bodily Sensations. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-91-1-63
55. Barsky, A. J. (1986). Palliation and symptomatic relief. Archives of Internal Medicine. https://doi.org/10.1001/archinte.146.5.905
56. Barsky, A. J. (1986). Palliation and Symptomatic Relief. Archives of Internal Medicine. https://doi.org/10.1001/archinte.1986.00360170115018
57. Barsky, A. J. (1999). Functional Somatic Syndromes. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-130-11-199906010-00016
58. Barton, S., Karner, C., Salih, F., Baldwin, D. S., & Edwards, S. J. (2014). Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review. Health Technology Assessment. https://doi.org/10.3310/hta18500
59. Bartova, L., Dold, M., Volz, H. P., Seifritz, E., Möller, H., & Kasper, S. (2025). ANTIDEPRESSANT EFFECTS OF SILEXAN IN PATIENTS WITH PRIMARY ANXIETY SYNDROMES. The International Journal of Neuropsychopharmacology. https://doi.org/10.1093/ijnp/pyae059.065
60. Batinić, B., Duišin, D., & Vukosavljevic-Gvozden, T. (2017). Neurobiological bases for impulsive and compulsive behaviour: Implications for pharmacological and psychological interventions. Engrami. https://doi.org/10.5937/engrami1701017b
61. Batta, A., & Farid, B. (2011). Addiction in Adolescents ---- A Current Trend.
62. Baum, R., & Campo, J. V. (2022). Medically Unexplained Symptoms. Pediatric Care Online. https://doi.org/10.1542/aap.ppcqr.396501
63. Bauman, K. A. (2009). Sexually transmitted diseases. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511642111.012
64. Baxter, P. (2015). States of consciousness: new insights and further questions. Developmental Medicine & Child Neurology. https://doi.org/10.1111/dmcn.12666
65. Beaudreau, S. A., & Gould, C. E. (2015). Definition of Mental Disorder. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa190
66. Becher, S., Montag, A., & Weber, K. (1995). UMWELTLAERM ALS GESUNDHEITLICHE BEDROHUNG.
67. Becker, M. A., Weinberger, T. E., & Ocker, L. J. (2022). Mood Disorders. CRC Press eBooks. https://doi.org/10.1201/9781003099062-21
68. Belgers, M., & Schellekens, A. (2021). Stoornis in het gebruik van een middel. https://doi.org/10.1007/978-90-368-2586-3_15
69. Belik, S., Sareen, J., & Stein, M. B. (2008). Anxiety Disorders and Physical Comorbidity. Oxford University Press eBooks. https://doi.org/10.1093/oxfordhb/9780195307030.013.0046
70. Benjamin, S., & Eminson, D. M. (1992). Abnormal illness behaviour: childhood experiences and long-term consequences. International Review of Psychiatry. https://doi.org/10.3109/09540269209066302
71. Benítez, M. S. H., Castresana, C. D. L. C., Revuelta, J. L. G. D. R. Y., & Marco, R. G. (1991). Relevancia de factores psicosociales en el aparato respiratorio. Psiquis: Revista de psiquiatría, psicología médica y psicosomática.
72. Berkowsky, R. W. (2014). Aging and Stress. The Wiley Blackwell Encyclopedia of Health, Illness, Behavior, and Society. https://doi.org/10.1002/9781118410868.wbehibs020
73. Bersani, F. S., Mellon, S. H., Reus, V. I., & Wolkowitz, O. M. (2019). Accelerated aging in serious mental disorders. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0000000000000525
74. Bertodo, T. D. S., Gross, M. S., & Maldaner, E. B. (2018). TRANSTORNOS BIPOLAR E DEPRESSIVO: UMA REVISÃO DOS ASPECTOS CONCEITUAIS.
75. Bezerra, E. D. L., & Zimmermann, M. (2015). DISTÚRBIOS COMPORTAMENTAIS EM CÃES: Ansiedade por Separação.
76. Bhowmik, D., Kumar, K. S., Srivastava, S., Paswan, S. K., & Dutta, A. S. (2012). Depression - Symptoms, Causes, Medications and Therapies. Deleted Journal.
77. Bibi, E. S. D. M. (2021). AN OVERVIEW OF POST WAR SOCIAL PROBLEMS IN SYRIA. Pakistan Journal of International Affairs. https://doi.org/10.52337/pjia.v2i2.63
78. Bilal, A., & Naveed, N. (2022). Biological Rhythms, Disorders and their Energetic : A Review. Journal of Internal Medicine Research & Reports. https://doi.org/10.47363/jimrr/2022(1)104
79. Bismuth, C., Bellec, L., Dally, S., & Lagier, G. (1980). [Benzodiazepine physical dependence. 6 cases (author's transl)].. PubMed.
80. Black, K. J. (2020). Case Report: DSM–5 misses an edge case in tic disorders nosology. F1000Research. https://doi.org/10.12688/f1000research.23991.1
81. Blanco, C., & Bernardi, S. (2014). Gambling Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg62
82. Blaney, P. H. (2015). Medical Model of Mental Disorders. The Encyclopedia of Clinical Psychology. https://doi.org/10.1002/9781118625392.wbecp382
83. Blay, S. L. (2011). A Case of Major Depressive Disorder and Symptoms of Polycystic Ovary Syndrome Responding to Escitalopram. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.11l01183
84. Blümel, J. E., & Arteaga, E. (2017). Los riesgos de no usar terapia hormonal de la menopausia: deterioro de la calidad de vida. Revista médica de Chile. https://doi.org/10.4067/s0034-98872017000600760
85. Boeft, M. D., Dessel, N. C.-V., & Wouden, J. C. V. D. (2017). How should we manage adults with persistent unexplained physical symptoms?. BMJ. https://doi.org/10.1136/bmj.j268
86. Bokin, K. (2021). Psychotherapy Utilization among Old People with Post-Traumatic Stress Disorder. Journal of Yoga & Physical Therapy. https://doi.org/10.35248/2157-7595.21.s6.004
87. Bolten, M., & Légeret, C. (2021). Interface entre pédopsychiatrie et pédiatrie – illustré par le concept bâlois du traitement interdisciplinaire des troubles fonctionnels de la défécation. Paediatrica Métabolisme/maladies rares. https://doi.org/10.35190/f2021.2.1
88. Bolton, E., Holohan, D. R., King, L. A., & King, D. W. (2004). Acute and Post-Traumatic Stress Disorder. Routledge eBooks. https://doi.org/10.4324/9780203336960-13
89. Bond, C., Morgenstern, J., & Milne, W. K. (2022). Hot off the press: <scp>MRI</scp> sensitivity for transient global amnesia. Academic Emergency Medicine. https://doi.org/10.1111/acem.14540
90. Bonevski, D., & Naumovska, A. (2018). Trauma and Anxiety Disorders throughout lifespan: Fear and anxiety from normality to disorder.. PubMed.
91. Bonnet, M. H., & Arand, D. L. (2008). Chronic insomnia. CRC Press eBooks. https://doi.org/10.3109/9780203091715-12
92. Bortkiewicz, A., & Czaja, N. (2018). Pozasłuchowe skutki działania hałasu ze szczególnym uwzględnieniem chorób układu krążenia.
93. Bostankolu, G., Ayhan, Y., Çetin, F. Ç., & Yazıcı, M. K. (2014). Serotonin syndrome with a combination of aripiprazole and fluoxetine: a case report. Therapeutic Advances in Psychopharmacology. https://doi.org/10.1177/2045125314561467
94. Bousfield, L. (2010). The Perception of Pain: 'The Pain Is Still There but It Doesn't Hurt as Much'.
95. Bouvard, M., Milliery, M., & Cottraux, J. (2004). Management of Obsessive Compulsive Disorder. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000076452
96. Bran, C. (2021). BURNOUT VERSUS WELL-BEING IN ORGANIZATIONS. Journal Plus Education.
97. Brauer, A. A. (2021). Psychosocial Aspects of Sport Retirement Amongst Collegiate Student-Athletes in the United States. Routledge eBooks. https://doi.org/10.4324/9781003020189-4
98. Brech, G. C., Andrusaitis, S. F., Vitale, G. F., & Greve, J. M. D. (2012). Correlation of disability and pain with postural balance among women with chronic low back pain. Clinics. https://doi.org/10.6061/clinics/2012(08)17
99. Broglin, D. (2009). Troubles sexuels chez les patients épileptiques. Epilepsies. https://doi.org/10.1684/epi.2009.0277
100. Bromberger, J. T., & Woods, N. F. (2009). Nonhormonal Factors Associated with Psychiatric Morbidity during the Menopausal Transition and Midlife. Key issues in mental health (Online)/Key issues in mental health (Print). https://doi.org/10.1159/000209601
101. Bron, D. (2002). Fatigue et qualité de vie chez les patients cancéreux.. Revue Medicale de Bruxelles.
102. Broomfield, N. M., Wild, M. R., & Espie, C. A. (2008). Assessment and treatment of insomnia in later life. Oxford University Press eBooks. https://doi.org/10.1093/med:psych/9780198569459.003.0011
103. Brown, T. A., & Lawrence, A. E. (2008). Generalized Anxiety Disorder and Obsessive-Compulsive Disorder. https://doi.org/10.1093/oso/9780195374216.003.0006
104. BS, A. H., & BA, M. F. (2018). Glossary. https://doi.org/10.1002/9781119449737.gloss
105. Budson, A. E., & O’Connor, M. K. (2021). How to manage emotional problems. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780190098124.003.0008
106. Buljan, D. (2009). Psychological and psychiatric factors of chronic pain.
107. Burk, A., Merchant, A., Rahman, H., Patel, A., Deshmukh, I., Merchant, R., Yam, A. A., Yu, A., Cai, C., Hassam, A., Le, D., & Lambroussis, C. G. (2025). Serotonin Syndrome Without Overdose: Polypharmacy-Induced Toxicity in a Medically Stable Young Adult. Cureus. https://doi.org/10.7759/cureus.86587
108. Burton, K., & Kendall, N. (2014). ABC of Occupational and Environmental Medicine, 3rd EditionMusculoskeletal Disorders.
109. Busse, J. W. (2007). The Neuroendocrinology of Medically Unexplained Syndromes. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-008-9_23
110. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Le trouble hyperkinétique ou déficit de l'attention/hyperactivité. Le point sur... Psychologie.
111. Bénony, H., Bénony-Viodé, C., & Dumas, J. (2012). Les troubles de l'humeur. Le point sur... Psychologie.
112. Büyüktuncer, Z., & Isgin, K. (2017). Nutritional approach in premenstrual syndrome. Turkish Bulletin of Hygiene and Experimental Biology. https://doi.org/10.5505/turkhijyen.2017.46667
113. Băcilă, C., Anghel, C. E., & Vulea, D. (2019). Ethical aspects in the management of postpartum depression. Sæculum. https://doi.org/10.2478/saec-2019-0022
114. Calabrese, P. (2021). Impact of Mental Disorder in Human Being.
115. Callaghan, P., & Waldock, H. (2006). Chapter 10 Older people. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198568988.003.0010
116. Camba, E. R. (2019). Evaluación de la regulación emocional cognitiva en fibromialgia mediante el instrumento cognitive emotion regulation (cerq).
117. Cambra, P. R. (2021). Trastorno mental grave, pacientes con esquizofrenia.. Revista Sanitaria de Investigación.
118. Campling, F., & Sharpe, M. (2008). Difficulties with memory and concentration. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199233168.003.0018
119. Campling, F., & Sharpe, M. (2008). Managing anxiety, panic, and depression. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199233168.003.0022
120. Caraiane, A., Szalontay, A. S., Macovei, L. A., Romila, A., Indrei, L. L., Decusară, M., & Tarc, T. (2018). Oral-Facial Manifestations Caused by the Use of Psychotropic Medication in Psychiatric Patients. Revista de Chimie. https://doi.org/10.37358/rc.18.6.6374
121. Cardoso, J. M. G., Marinho, K. K., Pereira, I. A. B., Costa, E. S. S. D., Vitória, B. T. D., Lino, A. T. D. S., Oliveira, B. N., Ribeiro, M. E. S., Pereira, G. M., Vitória, B. T. D., Vitória, B. T. D., Vasco, E., Ramos, G. O. S., Teodoro, G. A. P., & Ribeiro, S. V. (2024). PRINCIPAIS E INOVADORAS MEDIDAS FARMACOLÓGICAS PARA O TRATAMENTO DO TRANSTORNO DEPRESSIVO MAIOR. Revista Contemporânea. https://doi.org/10.56083/rcv4n4-127
122. Casanova, Y. C., Torres, M. N., Ramírez, M. D. L., Ferrer, A. B., Calvo, R. N., & Ramos, I. J. (2021). Plan de cuidados de enfermería para paciente con deterioro de la movilidad.. Revista Sanitaria de Investigación.
123. Castaño-Cárcamo, M., Escobar-Córdoba, F., & Castro, J. R. D. (2014). [Restless Legs Syndrome : A Threat to the quality of life].. PubMed.
124. Cha, Y., Baloh, R. W., Cho, C., Magnusson, M., Song, J., Strupp, M., Wuyts, F. L., & Staab, J. P. (2020). Mal de débarquement syndrome diagnostic criteria: Consensus document of the Classification Committee of the Bárány Society. Journal of Vestibular Research. https://doi.org/10.3233/ves-200714
125. Chaijan, P. Y., Salehi, B., Khosrobeigi, A., Hajirahimi, M., Rafiei, M., & Ahmadi, H. T. (2014). Prevalence of Obsessive-Compulsive Disorder in Pediatric Patients with the Daytime Frequency Syndrome of Childhood or Pollakiuria. Journal of Arak University of Medical Sciences.
126. Chakma, P., & Goswami, H. (2021). Burden &amp; Coping in Caregivers of Persons with Dementia. Eastern Journal of Psychiatry. https://doi.org/10.5005/ejp-19-1-18
127. Chandra, D., Raj, K. S., & Prema (2018). Obstructive Sleep Apnea and Its Prosthodontic Management- An Overview. International Journal of Health Sciences and Research.
128. Chaouki, F., Djebbar, A., & Drias, D. (2021). Sleep disorders & Hormones: how are they related?. Batna Journal of Medical Sciences (BJMS). https://doi.org/10.48087/bjmsra.2021.8207
129. Charante, E. P. M. V., Richard, E., & Perry, M. (2022). [Forgetfulness].. PubMed.
130. Chen, Z., & Gong, Q. (2021). Resting-State Functional Connectivity in Unipolar Depression. Cambridge University Press eBooks. https://doi.org/10.1017/9781108623018.007
131. Chettri, D. K., Thapa, P. R., & Rana, K. K. (2021). Physiological Effects of Acute and Chronic Stress in Human Body. Turkish Online Journal of Qualitative Inquiry.
132. Chiliza, B., & Vythilingum, B. (2011). Consultation liaison psychiatry in Africa – essential service or unaffordable luxury?. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v14i4.1
133. Cho, C. (2005). Clinical Implications of Aging and Characteristics of Illnesses of the Aged. Journal of the Korean Medical Association. https://doi.org/10.5124/jkma.2005.48.1.15
134. Choi, S. J. (2007). Sleep Breathing Disorder. Tuberculosis & respiratory diseases. https://doi.org/10.4046/trd.2007.63.1.5
135. Cienfuegos, J. J., Arriaga, M. Á. A., García, J. J., & Fernández, A. C. S. (2021). Propuesta de establecimiento de hábitos y rutinas que contemplen ejercicio y manejo del estrés para evitar el desgaste laboral durante el home office. Ciencia Latina Revista Científica Multidisciplinar. https://doi.org/10.37811/cl_rcm.v5i3.583
136. Citrome, L. (2015). A primer on binge eating disorder diagnosis and management. CNS Spectrums. https://doi.org/10.1017/s1092852915000772
137. Clauw, D. J. (2010). Perspectives on Fatigue from the Study of Chronic Fatigue Syndrome and Related Conditions. PM&R. https://doi.org/10.1016/j.pmrj.2010.04.010
138. Coghill, D., Bonnar, S., Duke, S., Graham, J., & Seth, S. (2009). Obsessive compulsive disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199234998.003.0020
139. Colán, T. C., Gálvez, G. A., & Zevallos, D. C. (2013). Síntomas psiquiátricos e insulinoma: reporte de caso Psychiatric symptoms and insulinoma: a case report.
140. Compton, M. T., & Broussard, B. (2010). Psychosocial Treatments for Early Psychosis. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195372496.003.0016
141. Conway, K. P., Montoya, I. D., & Compton, W. M. (2007). Lifetime Psychiatric Comorbidity of Illicit Drug Use Disorders. The Psychiatric times.
142. Costa, E. G., Elizio, G., Raimundo, J., Fajardo, L., & Abreu-Freire, N. D. S. (2022). Analgesia não medicamentosa no processo de parturição: revisão sistemática da literatura. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.13
143. Cox, R. C., Wright, K. P., Axelsson, J., & Balter, L. J. T. (2024). Diurnal variation in anxiety and activity is influenced by chronotype and probable anxiety-related disorder status. Psychiatry Research. https://doi.org/10.1016/j.psychres.2024.116006
144. Cristovam, M. A. D. S., Muzzolon, S. R. B., & Santos, L. H. C. D. (2019). Application of Youth Self-Report for Age 11-18 for Screening of Mental Disorders in the Adolescence. Mathews Journal of Pediatrics. https://doi.org/10.30654/mjp.10019
145. Cuijpers, P. (2010). Postpartum Depression. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0697
146. Cullum, S., Tucker, S., & Dening, T. (2007). Management problems. CRC Press eBooks. https://doi.org/10.3109/9781420075052-11
147. Curto, M. P. M., & Quintana, M. V. M. (2009). [Co-morbility during depression].. PubMed.
148. Czajkowska‐Malinowska, M., & Cofta, S. (2014). Obturacyjny bezdech senny i jego społeczne następstwa.
149. Cárdenas, J. F., & McLeod, T. C. V. (2024). Are There Any Medications That May Be Useful in the Management of Concussions?. Routledge eBooks. https://doi.org/10.4324/9781003526131-31
150. Dadsetan, P., Lazarus, R. S., & Jahangiri, H. (2019). Stress: Treatment, and Management. LAP LAMBERT Academic Publishing eBooks.
151. Dahlem, M. A., Mair, T., & Müller, S. C. (2004). Spatio-Temporal Aspects of a Dynamical Disease: Waves of Spreading Depression. Birkhäuser Basel eBooks. https://doi.org/10.1007/978-3-0348-7895-1_42
152. Dahm, K. T., Holte, H. H., Dalsbø, T. K., Straumann, G. H., & Reinar, L. M. (2017). Effect of Physical Activity without Use of Antipsychotics Compared to Physical Activity and Antipsychotics for Patients with Active Psychosis: A Systematic Review [Internet].
153. Daley, D. C., & Douaihy, A. (2019). Substance-Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190926632.003.0002
154. Dana, A. I. (2021). Mild Cognitive Impairment is an Early Stage of Memory Loss. Journal of Aging and Geriatric Medicine.
155. Dasch‐Yee, K. B. (2020). Anxiety, Assessment of. The Wiley Encyclopedia of Personality and Individual Differences. https://doi.org/10.1002/9781118970843.ch105
156. Dashinie, S., & Renganathan, S. (2014). Major Depressive Disorder without Psychotic Features- A Case Report.
157. Davies, S., & Heyman, I. (2004). Psychiatric aspects. CRC Press eBooks. https://doi.org/10.1201/b13560-60
158. Davis, K. (2009). Evaluation of University of Buffalo's ADHD Summer Treatment Program developed by Dr. William Pelham, Jr., based on evidence-based treatments of ADHD.
159. Davoine, G.-A., Godinat, G., Petite, D., & Saurer, A. (2013). [Medically unexplained persistent pain syndrome: psychoanalytic approach].. PubMed.
160. Dean, G., & Wadia, N. H. (1995). Multiple sclerosis in the Parsis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254
161. Delanerolle, G., Shetty, S., Raymont, V., Hapangama, D. K., Haque, N., Shi, J. Q., Ayis, S., Shetty, A., & Phiri, P. (2021). None. LOJ Medical Sciences. https://doi.org/10.32474/lojms.5.5
162. DeLuca, G. C., & Bartleson, J. D. (2010). When and How to Investigate the Patient with Headache. Seminars in Neurology. https://doi.org/10.1055/s-0030-1249221
163. Dembert, M. L. (1986). Sick Santa Syndrome. JAMA. https://doi.org/10.1001/jama.1986.03380230040016
164. Dennis, M., Warlow, C. P., Gijn, J. V., Wardlaw, J. M., Bamford, J., Hankey, G. J., Sandercock, P., Rinkel, G. J., Langhorne, P., Sudlow, C., & Rothwell, P. M. (2008). What are This Patient's Problems?: A Problem‐Based Approach to the General Management of Stroke. Stroke. https://doi.org/10.1002/9780470696361.ch11
165. Derman, E., Whitesman, S., Dreyer, M., Patel, D., Nossel, C., & Schwellnus, M. (2010). Healthy lifestyle interventions in general practice: Part 12: Lifestyle and depression. South African Family Practice. https://doi.org/10.1080/20786204.2010.10873989
166. Dervaux, A. (2013). En quoi et comment le cannabis peut-il être toxique pour le cerveau ?. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2013.09.004
167. Desai, G., Chaturvedi, S. K., & Bhugra, D. (2020). Cultural Spectrum of Chronic Pain and Somatization Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190248253.003.0027
168. Dhobe, S., Gujar, S., & Sc, M. (2021). Prevalence of Associated Factors of Depressive Symptoms among School Going Children’s. Indian Journal of Forensic Medicine & Toxicology. https://doi.org/10.37506/ijfmt.v15i1.13470
169. Diarra, E., Jedynak, C. P., & Verny, M. (2008). [Tremor in the elderly].. PubMed. https://doi.org/10.1684/pnv.2008.0139
170. Dias, R. D. S. (2010). Estudo comparativo do fenótipo clínico de mulheres com transtorno afetivo bipolar em fase reprodutiva da vida com e sem piora pré-menstrual do humor. https://doi.org/10.11606/t.5.2010.tde-28052010-101220
171. Dilsaver, S. C., & Coffman, J. A. (1988). Seasonal depression.. PubMed.
172. Dilsaver, S. C., Halle, M. H., & Medico, V. J. D. (1991). Symptoms of major depression: acute effect of withdrawing antidepressants. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1991.tb05531.x
173. Dini, D., Harahap, F. S. D., Syahuri, F., Almayda, P., & Divani, D. A. (2022). Pengaruh Kesehatan Mental Terhadap Prestasi Belajar Siswa SMP Negeri 1 Jebus. Jurnal Ilmiah Bimbingan Konseling Undiksha. https://doi.org/10.23887/jibk.v13i1.43679
174. Dolenc, T. J. (2015). Substance Use Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190214883.003.0044
175. Domźał, T., Załeska, B., Kwasucki, J., & Gierczak-Walichnowska, J. (1980). [Diurnal rhythm of pain in sciatica. Preliminary report].. PubMed.
176. Drach, L. M., & Terner, B. (2007). Das gerissene soziale Netz des älteren Patienten neu weben. Zeitschrift für Gerontopsychologie & -psychiatrie. https://doi.org/10.1024/1011-6877.20.23.89
177. Dragoș, D., & Tănăsescu (2009). The critical role of psychosomatics in promoting a new perspective upon health and disease.. Journal of Medicine and Life.
178. Dreyer-Oren, S. E., Mitnaul, L., & Holtzheimer, P. E. (2018). Mood Disorders. American Psychiatric Association Publishing eBooks. https://doi.org/10.1176/appi.books.9781615372423.sy25
179. Dudek, D., & Sobański, J. A. (2012). Mental disorders in somatic diseases: psychopathology and treatment. Polskie Archiwum Medycyny Wewnętrznej. https://doi.org/10.20452/pamw.1539
180. Dugue, M., & Neugroschl, J. (2002). Anxiety disorders. Helping patients regain stability and calm.. PubMed.
181. Duică, L., & Pîrlog, M. (2018). Comportamentul suicidar şi domeniul psihosomaticii. Psihiatru ro.
182. Duică, L., & Pîrlog, M. (2018). Suicidal behavior and the area of psychosomatics. Psihiatru ro. https://doi.org/10.26416/psih.51.4.2017.1360
183. Duits, N., & Bos, F. M. (1993). [Psychiatric disorders with use of simvastatin].. PubMed.
184. Duletic, N., Mijatovic-Papic, T., Cizmovic, B., & Kusturica, S. (2015). Differential Diagnostic Consideration of the Syndrome of Psychomotor Agitation in Geriatric Population. European Psychiatry. https://doi.org/10.1016/s0924-9338(15)31130-5
185. Dunn, K. M., & Croft, P. (2004). Epidemiology and natural history of low back pain.. PubMed.
186. Duval, F., Jautz-Duval, M. M., González, F., & Rabia, H. (2010). Bases neurobiológicas de vulnerabilidad psiquiátrica a lo largo de las etapas de la vida hormonal de la mujer. Revista chilena de neuro-psiquiatría. https://doi.org/10.4067/s0717-92272010000500005
187. Délano, P. H., Holmes, A., & Díaz, C. (2022). Mal de desembarque. Revista de otorrinolaringología y cirugía de cabeza y cuello. https://doi.org/10.4067/s0718-48162022000300343
188. D’Souza, R. S., & Hooten, W. M. (2019). Somatic Syndrome Disorders.
189. Eberlein-König, B., Rakoski, J., Ruhdorfer, S., Huss‐Marp, J., Grimm, V., Behrendt, H., & Ring, J. (2003). Idiopathic Environmental Intolerances: Psychosomatic and Somatic Aspects. Dermatology and Psychosomatics / Dermatologie und Psychosomatik. https://doi.org/10.1159/000070534
190. Ebzeeva, E. Y., & Polyakova, O. A. (2022). Stress and stress-induced disorders. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2022-16-2-127-133
191. Egbert, A. M. (1993). 'The dwindles'. Failure to thrive in older patients.. PubMed.
192. Ekkekakis, P. (2014). Physical activity and feeling good. https://doi.org/10.4324/9781315880198-57
193. Ekuri, P., & Edim, M. E. (2014). Relevance of Physical Activity in the Treatment and Prevention of Mild and Severe Mental Health Problems. Studies in sociology of science. https://doi.org/10.3968/4442
194. El-Hamady, M. M., El-Sayed, H., Bakry, S. E., & Youniss, M. (2020). Prevalence of Anxiety Disorders in Substance Related Disorders. Benha Journal of Applied Sciences. https://doi.org/10.21608/bjas.2020.137193
195. Enrique, P. M. L., Gloria, A. S., Efraín, S. C. J., & Luis, G. A. J. (2019). Latencia diagnóstica en la enfermedad de Parkinson y su relación con los síntomas prodrómicos motores y no motores. eNeurobiología.
196. Ensalada, L. H., Brigham, C. R., & Kertay, L. (2018). Somatization. AMA guides newsletter. https://doi.org/10.1001/amaguidesnewsletters.2018.julaug03
197. Escribano, S. A. (2018). Estudio de la eficacia de un tratamiento psicológico breve en la disminución de la sensibilidad a la ansiedad en pacientes con trastorno de pánico.
198. Espinoza, H., & Vicente, J. (2015). Trastorno por ansiedad en paciente de 46 años de escolarización medio con tratamiento psicoterapéutico en modelo psicológico cognitivo conductual..
199. Evi, E., Wiguna, T., & Malik, K. (2021). KOMORBIDITAS GANGGUAN TIDUR PADA ANAK DENGAN GANGGUAN PEMUSATAN PERHATIAN DAN HIPERAKTIVTAS. Jurnal Muara Medika dan Psikologi Klinis. https://doi.org/10.24912/jmmpk.v1i1.12086
200. Falcão, F. A., Santos, A. L. D., Barbosa, D. C. B., & Santos, T. R. D. (2022). Responsabilidade civil no erro médico e dano moral. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.25
201. Falk, A., Joseph, R., Smith, S., & Wilk, A. (2023). Mood and Anxiety Disorders: Major Depressive Disorder.. PubMed.
202. Faran, S., Vatine, J., Lazary, A., Ohry, A., Birbaumer, N., & Kotchoubey, B. (2006). Late recovery from permanent traumatic vegetative state heralded by event-related potentials. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.2005.076554
203. Faravelli, C., Zucchi, T., Perone, A., Salmoria, R., & Viviani, B. (2001). Social Phobia. https://doi.org/10.1002/0470846437.ch7
204. Fava, M. (2003). Symptoms of fatigue and cognitive/executive dysfunction in major depressive disorder before and after antidepressant treatment.. PubMed.
205. Fawei, C., Ya-ping, M., & Lin, Y. (2008). gao san xue sheng jiao lv yi yu qing xu yu sheng huo shi jian he ying dui fang shi de xiang guan xing. Zhonghua xingwei yixue yu naokexue zazhi. https://doi.org/10.3760/cma.j.issn.1005-8559.2008.01.029
206. Fernandes, T. D. J., Mendes, E., Preto, L., & Novo, A. (2015). Effect of a mobilization and active exercise program on the range of motion of bedridden patients with disuse syndrome.
207. Ferrara, P. (2014). Child abuse and neglect: psychiatric and neuro-biological consequences. The Italian Journal of Pediatrics/Italian journal of pediatrics. https://doi.org/10.1186/1824-7288-40-s1-a32
208. Ferreira, R. B., & Bottino, C. M. C. (2011). Transtornos do humor em idosos. Debates em Psiquiatria. https://doi.org/10.25118/2763-9037.2011.v1.869
209. Fiar, Z., Hroudov, J., & Raboch, J. (2012). Neurotransmission in Mood Disorders. InTech eBooks. https://doi.org/10.5772/31831
210. Fiebai, P. O., Ukueku, A. O., & Ogu, R. (2019). Pre Menstrual Syndrome. IntechOpen eBooks. https://doi.org/10.5772/intechopen.80492
211. filho, C. S. T., Lazzaretti, C., & Netto, G. C. (2018). Prevalência de insônia no município de Osório/RS de 2009 a 2016. MoExP - Mostra de Ensino, Extensão e Pesquisa do Campus Osório.
212. Fine, L., Dubrovsky, B., & Spielman, A. J. (2011). Insomnia. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805153311101010137
213. Fink, M. (2010). Depressive Mood Disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195365740.003.0009
214. Fink, P. (2005). None. Tidsskrift for Forskning i Sygdom og Samfund. https://doi.org/10.7146/tfss.v3i5.495
215. Finlayson, R. E. (1989). Recognition and management of dysthymic disorder.. PubMed.
216. Fisher, A. D., Bandini, E., Casale, H., & Maggi, M. (2011). Paraphilic Disorders: Diagnosis and Treatment. https://doi.org/10.1002/9781119963820.ch8
217. Fiske, A., Wetherell, J. L., & Gatz, M. (2009). Depression in Older Adults. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.032408.153621
218. Folks, D. G., & Ford, C. V. (2002). Clinical Features of Depression and Dysthymia. https://doi.org/10.1002/0470846410.ch74
219. Ford, C. V. (1992). Illness as a Lifestyle. Spine. https://doi.org/10.1097/00007632-199210001-00001
220. Ford, C. V. (1997). Somatic symptoms, somatization, and traumatic stress: An overview. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489709109078
221. Ford, K. (2017). Nutritional and environmental management of PMS. Journal of the Australasian College of Nutritional and Environmental Medicine.
222. Fornera, R. (2019). Strategie di coping per far fronte al distress nell’infermiere specialista clinico in salute mentale e psichiatria.
223. Franz, M. R., & Schepank, H. (1997). [Mood disorders. Prevalence and course of unspecified functional disorders from the epidemiologic and psychosomatic viewpoint].. PubMed.
224. Freeman, D., & Freeman, J. (2012). 7. Panic disorder. Anxiety. https://doi.org/10.1093/actrade/9780199567157.003.0007
225. Fried, R. G., Friedman, S., Paradis, C. M., Hatch, M., Lynfield, Y. L., DUNCANSON, C., & Shalita, A. R. (1995). TRIVIAL OR TERRIBLE? THE PSYCHOSOCIAL IMPACT OF PSORIASIS. International Journal of Dermatology. https://doi.org/10.1111/j.1365-4362.1995.tb03588.x
226. Friedman, K. J., Mattey, B., & Newton, F. (2018). School Nurses Can Improve the Lives of Students With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. NASN School Nurse. https://doi.org/10.1177/1942602x18795299
227. Fritzsche, K. (2019). Anxiety Disorders and Obsessive Compulsive Disorder. Psychosomatic Medicine. https://doi.org/10.1007/978-3-030-27080-3_9
228. Fritzsche, K. (2019). Somatic Symptom Disorder. Psychosomatic Medicine. https://doi.org/10.1007/978-3-030-27080-3_10
229. Gameiro, G. R., Minguini, I. P., & Alves, T. C. T. F. (2014). O papel do estresse e de acontecimentos cotidianos para o desenvolvimento da depressão na terceira idade. Revista de Medicina. https://doi.org/10.11606/issn.1679-9836.v93i1p31-40
230. Ganasan, S. (2019). Managing depression in the primary care setting. Journal of Prescribing Practice. https://doi.org/10.12968/jprp.2019.1.8.388
231. García, C. M. (2008). Programa de fomento de ejercici físico para disminuir la ansiedad en pacientes psiquiátricos. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
232. Garg, N., & Weinstock-Guttman, B. (2007). Treatment of pain, paresthesias and paroxysmal disorders in multiple sclerosis. CRC Press eBooks. https://doi.org/10.3109/9780203012055-57
233. Garrabé, J., & Cousin, F. (2012). Acute and transient psychotic disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199696758.003.0081
234. Gaynor, A. M., Hartley, H., & Sands, S. A. (2020). Physical and Cognitive Rehabilitation for Children with Brain and Spinal Tumors. CRC Press eBooks. https://doi.org/10.1201/9781003090120-8
235. Gedde‐Dahl, T., Apelland, T., & Dietrichson, T. (1999). [Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors].. PubMed.
236. Geng, J., Yan, R., & Yao, Z. (2018). Biological mechanisms of somatic symptoms in depressive disorder. Zhonghua xingwei yixue yu naokexue zazhi. https://doi.org/10.3760/cma.j.issn.1674-6554.2018.12.019
237. George, M. (1997). Depression in older people. Nursing Standard. https://doi.org/10.7748/ns.11.28.26.s39
238. Gerc, K., & Makiełło-Jarzowa, G. (1998). [Psychological consequences of neurologic motor impairment from a developmental perspective].. PubMed.
239. Giacomo, E. D., Moretti, F., Colmegna, F., & Clerici, M. (2023). Obsessive–compulsive disorder as the onset of bipolar disorder in adolescence. Bipolar Disorders. https://doi.org/10.1111/bdi.13373
240. Gjerdingen, D. K., Froberg, D. G., & Wilson, D. L. (1986). Postpartum mental and physical problems. Postgraduate Medicine. https://doi.org/10.1080/00325481.1986.11699637
241. Gleason, M. M., & Thompson, L. A. (2022). Depression and Anxiety Disorder in Children and Adolescents. JAMA Pediatrics. https://doi.org/10.1001/jamapediatrics.2022.0052
242. Godiawala, S. P., Parikh, M., & Kumar, R. (2024). Unraveling the Diagnostic Challenge: A Case Report on Disruptive Mood Dysregulation Disorder. Indian Journal of Clinical Psychiatry.. https://doi.org/10.54169/ijocp.v4i02.118
243. Gold, B. G., Schnell, J. V., & Spencer, P. S. (2003). Neurotoxic Disorders. https://doi.org/10.1007/978-1-4757-4552-8_14
244. Goldberg, S., & Chapman, J. (2014). Practice question. Nursing Older People. https://doi.org/10.7748/nop.26.10.14.s18
245. Goldenberg, D. L., & Dichter, M. A. (2022). Long‐COVID Disease or Long‐COVID Syndrome?. https://doi.org/10.1002/9781119891338.ch1
246. Golding, J. M. (1999). Sexual-Assault History and Long-Term Physical Health Problems. Current Directions in Psychological Science. https://doi.org/10.1111/1467-8721.00045
247. Gomes, F. W. C., Braga, K. L., Gabriel, I. D. S., Varela, B. R. S., & Feitosa, A. D. N. A. (2023). O PAPEL DO TRATAMENTO FARMACOLÓGICO E NÃO FARMACOLÓGICO NA REDUÇÃO DE RECIDIVA NO TRANSTORNO DE ANSIEDADE GENERALIZADA. Revista interdisciplinar em saúde. https://doi.org/10.35621/23587490.v10.n1.p210-221
248. Gooblar, J., & Beaudreau, S. A. (2018). Anxiety Disorders in Late Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.415
249. Goodyer, I., Herbert, J., Tamplin, A. K., & Altham, P. M. E. (2000). Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.177.6.499
250. Grant, I., Sacktor, N., & McArthur, J. C. (2005). HIV neurocognitive disorders. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198526100.003.0035
251. Greydanus, D. E., Calles, J. L., & Patel, D. R. (2008). Anxiety disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544705.007
252. Grosso, S., Cioni, M., Pucci, L., Morgese, G., & Balestri, P. (1999). Selective mutism, speech delay, dysmorphisms, and deletion of the short arm of chromosome 18: a distinct entity?. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.67.6.830
253. Grover, S., Sarkar, S., Jhanda, S., & Chawla, Y. (2014). Psychosis in an adolescent with Wilson′s disease: A case report and review of the literature. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.146530
254. Gruber, G., Saletu‐Zyhlarz, G., Anderer, P., Metka, M., Huber, J. C., Grätzhofer, E., & Saletu, B. (2007). Insomnia During Menopause. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-115-4_18
255. Gudelius, C., & Mielke, R. (2008). Fahrtuechtigkeit bei der Alzheimer-Erkrankung. SCHRIFTENREIHE FAHREIGNUNG.
256. Gudkova, M., Krymskaia, M. L., & Solov'ëva, A. D. (1994). [Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].. PubMed.
257. Guiraud, V., & Touzé, E. (2013). Psychological and Psychiatric Triggers and Risk Factors for Stroke. Neuropsychiatric symptoms of neurological disease. https://doi.org/10.1007/978-1-4471-2428-3_12
258. Guthrie, E., & Nayak, A. (2012). Medically unexplained symptoms.
259. Guthrie, M., Zubatsky, M., & Smith, C. W. (2015). Family Stress and Counseling. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_30-1
260. Ha, J. S. (2019). Depression in the Elderly and the Resources of Practical Theology. The Gospel and Praxis. https://doi.org/10.25309/kept.2019.8.15.232
261. Haboubi, N., & El-Masry, W. S. (2001). Aging and spinal cord injury. Reviews in Clinical Gerontology. https://doi.org/10.1017/s0959259801011376
262. Hafeza, M. J., Bourjia, H., & Sroura, H. (2020). Functional Neurological Deficit: one of the most controversial diagnosis- case report of a patient with paraplegia. International Journal of Case Reports. https://doi.org/10.28933/ijcr-2020-02-2305
263. Haffner‐Luntzer, M. (2025). MENTAL HEALTH AND BONE REGENERATION. Orthopaedic Proceedings. https://doi.org/10.1302/1358-992x.2025.7.099
264. Hainline, B., Gurin, L., & Torres, D. M. (2019). Anxiety Following Concussion. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0016
265. Hainline, B., Gurin, L., & Torres, D. M. (2019). Concussion Two Weeks Later. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190937447.003.0007
266. Hakan, M., & Kemal, A. R. (2009). Sporcularda Durumluk ve Sürekli Kaygi Düzeylerinin Bazi Değişkenlere Göre İncelenmesi Examxination Of The Level Of State - Trial Anxiety Of Sportsmen According To Some Variables.
267. Halligan, S. L. (2014). Neurobiological outcomes in the offspring of postnatally depressed mothers: Causes and consequences. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780199676859.003.0019
268. Halperin, I., & Korczyn, A. D. (2008). Depression precedes development of dementia. Harefuah.
269. Hammond, N., Bass, F., & Shehabi, Y. (2012). Memories and post-traumatic stress-related symptoms in older, post-cardiac surgery patients: substudy of an RCT. Critical Care. https://doi.org/10.1186/cc10949
270. Hand, I. (1995). Ambulante Verhaltenstherapie bei Zwangsstörungen. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-2007-1002291
271. Hansch, D. (2019). Angst und psychosomatische Erkrankungen: Eskalationsmechanismen und therapeutische Strategien aus der Sicht von Systemtheorie und Verhaltenstherapie. Therapeutische Umschau. https://doi.org/10.1024/0040-5930/a001091
272. Hansdah, R. S., Hembram, R. K., & Purty, A. (2024). A Comparative Study on Perceived Stress among Patients with Chronic Mental Illness, Caregivers of the Patients, and Normal Control. International Journal of Psychiatry. https://doi.org/10.33140/ijp.09.01.05
273. Hansenne, M., Kjiri, K., Ajamieh, A., & Ansseau, M. (1998). [Clinical case of the month. A case of Munchausen syndrome (factitious disorder)].. PubMed.
274. Hartanto, H., Hartono, B., & Nathawira, K. M. (2022). Sikap Berdiri Lama Dalam Menimbulkan Nyeri Punggung Bawah. Jurnal MedScientiae. https://doi.org/10.36452/jmedscientiae.v1i2.2661
275. Hartman, T. O., Lam, C. L. K., Usta, J., Clarke, D. D., Fortes, S., & Dowrick, C. (2018). Addressing the needs of patients with medically unexplained symptoms: 10 key messages. British Journal of General Practice. https://doi.org/10.3399/bjgp18x698813
276. Hartman, T. O., Woutersen-Koch, H., & Horst, H. E. V. D. (2013). Medically unexplained symptoms: evidence, guidelines, and beyond. British Journal of General Practice. https://doi.org/10.3399/bjgp13x675241
277. Hartung, P. J., & Penn, M. A. (2004). Work Stress and Health. https://doi.org/10.1093/oso/9780195149395.003.0041
278. Harvey, P. D. (2001). Cognitive impairment in elderly patients with schizophrenia: age related changes. International Journal of Geriatric Psychiatry. https://doi.org/10.1002/1099-1166(200112)16:1+<::aid-gps565>3.0.co;2-v
279. Hasanah, L. (2015). Penyakit Skizoafektif dengan Tipe Depresi pada Wanita 34 Tahun. Jurnal Medula.
280. Hauser, G., Tkalčić, M., Pletikosić, S., Sinčić, B. M., & Štimac, D. (2010). Can duration and severity of chronic bowel disease influence patients' psychosocial functioning?.
281. Hauser, G., Tkalčić, M., Pletikosić, S., Sinčić, B. M., & Štimac, D. (2011). Can duration and severity of chronic bowel disease influence patients' psychosocial functioning?.
282. Hautzinger, M. (1993). Depressionen. Verhaltenstherapie. https://doi.org/10.1007/978-3-662-22591-2_63
283. Hawkes, M. A., & Hocker, S. E. (2021). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0057
284. Hayes, J. M., & Koo, J. (2010). Psoriasis: depression, anxiety, smoking, and drinking habits. Dermatologic Therapy. https://doi.org/10.1111/j.1529-8019.2010.01312.x
285. Hechtman, L. (1991). Resilience and Vulnerability in Long Term Outcome of Attention Deficit Hyperactive Disorder. The Canadian Journal of Psychiatry. https://doi.org/10.1177/070674379103600606
286. Heilbroner, P. L., & Castaneda, G. Y. (2007). Pediatric neurology : essentials for general practice. Lippincott Williams & Wilkins eBooks.
287. Heinz, G. J. A. (2004). Entstehung, Diagnose und Früherkennung schizophrener Erkrankungen. psychoneuro. https://doi.org/10.1055/s-2004-823780
288. Hellhammer, D. H., & Wade, S. E. (1993). Endocrine Correlates of Stress Vulnerability. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000288675
289. Henna, E., Salesse, M. T., & Santos, M. M. D. (2018). Prevalência de transtorno mental comum e transtorno de personalidade em pacientes com diabetes mellitus tipo 1 atendidos no ambulatório do Conjunto Hospitalar de Sorocaba-SP. DOAJ (DOAJ: Directory of Open Access Journals).
290. Henriksson, J., & Sundberg, C. J. (2015). [Being in motion reduces the risk of disease and premature death].. PubMed.
291. Hida, A., Imaizumi, M., Sera, N., Akahoshi, M., Soda, M., Maeda, R., Nakashima, E., Nakamura, H., Ida, H., Kawakami, A., & Eguchi, K. (2010). Association of human T lymphotropic virus type I with Sjögren syndrome: Table 1. Annals of the Rheumatic Diseases. https://doi.org/10.1136/ard.2010.128736
292. Hirano, S., Ichikawa, Y., Sato, B., Takefuji, Y., & Satoh, F. (2023). Successful treatment of myalgic encephalomyelitis/chronic fatigue syndrome using hydrogen gas: four case reports. Medical Gas Research. https://doi.org/10.4103/2045-9912.385441
293. Ho, M.-K., & Siu, A. Y.-C. (2010). High Altitude Medicine.
294. Hocaoğlu, Ç., Yeloğlu, Ç. H., & Polat, S. (2011). Cardiac Diseases and Anxiety Disorders. https://doi.org/10.5772/intechopen.84024
295. Hokenson, R. E., Oijala, M., Short, A. K., Bolton, J. L., Chen, Y., Molet, J., Maras, P. M., Baram, T. Z., & Lür, G. (2020). Multiple Simultaneous Acute Stresses in Mice: Single or Repeated Induction. BIO-PROTOCOL. https://doi.org/10.21769/bioprotoc.3699
296. Holtzheimer, P. E., & Hamani, C. (2014). Deep brain stimulation for treatment-resistant depression. https://doi.org/10.2217/ebo.13.577
297. Hoogendijk, E., & Wijk, L. V. (1986). Chronische effecten tengevolge van blootstelling aan organische oplosmiddelen : literatuuronderzoek naar de effecten van blootstelling aan organische oplosmiddelen op het centrale zenuwstelsel. MIN SZW DGA eBooks.
298. Houssay, R. (2014). Las suprarrenales en la hipoxia o anoxia. Anales de la Facultad de Medicina. https://doi.org/10.15381/anales.v34i4.9544
299. Hranov, L. (2007). Comorbid anxiety and depression: illumination of a controversy. International Journal of Psychiatry in Clinical Practice. https://doi.org/10.1080/13651500601127180
300. Huda, A. S. (2019). Social factors and health. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198807254.003.0013
301. Hull, A., Reinhard, M. J., McCarron, K. K., Allen, N., Jecmen, M. C., Akhter, J. E., Duncan, A., & Soltes, K. L. (2014). Acupuncture and Meditation for Military Veterans: First Steps of Quality Management and Future Program Development. Global Advances in Health and Medicine. https://doi.org/10.7453/gahmj.2013.050
302. Iacovides, A., & Siamouli, M. (2008). Comorbid mental and somatic disorders: an epidemiological perspective. Current Opinion in Psychiatry. https://doi.org/10.1097/yco.0b013e328303ba42
303. Ice, G. H. (2018). Stress. The International Encyclopedia of Biological Anthropology. https://doi.org/10.1002/9781118584538.ieba0472
304. Imboden, C., Claussen, M. C., Seifritz, E., & Gerber, M. (2022). The Importance of Physical Activityfor Mental Health. Praxis. https://doi.org/10.1024/1661-8157/a003820
305. Ingrassia, G. F. (2012). HISTORICAL EVOLUTION OF MEDICAL KNOWLEDGE IN THE FIELD OF VEGETATIVE STATE.
306. Islam, M. T., Chowdhury, M. R., Snigdha, K. S. R., & Bhuiyan, M. S. I. (2014). Impact of Ankylosing Spondylitis on Paitents Work Status, Functional Disability and Quality of Life - A Review. BIRDEM Medical Journal. https://doi.org/10.3329/birdem.v4i2.33196
307. Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Psychedelics. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195380538.003.0606
308. Jafferany, M., & Pastolero, P. (2018). Psychiatric and Psychological Impact of Chronic Skin Disease. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.17nr02247
309. Jain, R. K., & Webb, D. R. (2016). Chronic pain : addressing the triad of pain, sleep and depression/anxiety : original. South African Journal of Diabetes.
310. Jain, S., Goel, S., & Kapila, S. (2015). Clinical Evaluation Of Psychiatric Emergencies.
311. James, T., & Somashekhar, L. M. (2021). Psychosis in Children and Young People. Child and Adolescent Mental Health. https://doi.org/10.4324/9781003083139-52
312. Jarosz, M., Syed, S., Błachut, M., & Badura-Brzoza, K. (2020). Emotional distress and quality of life in allergic diseases. Wiadomości Lekarskie. https://doi.org/10.36740/wlek202002131
313. Jeronimus, B. F. (2015). Environmental influences on neuroticism : a story about emotional (in)stability.
314. Jidhun, P., & Chitra, P. (2016). A Case Report on Childhood Dysthymia-Low Mood Triggers The End. International Journal of Nursing Education. https://doi.org/10.5958/0974-9357.2016.00079.9
315. Jimenez, B., & Lechuga, Y. A. (2019). La importancia del sueño en la vida cotidiana.
316. Jiménez, J. S., Vicent, A. C., & Garrigues, M. T. (2019). Trastorno Dismórfico Corporal: revisión sistemática de un trastorno propio de la adolescencia. Revista de Psiquiatría Infanto-Juvenil. https://doi.org/10.31766/revpsij.v36n1a1
317. Johnson, B. (2017). Somatic Symptom Disorders in Children.
318. Johnston, K. J., & Huckins, L. M. (2022). Chronic Pain and Psychiatric Conditions. Complex Psychiatry. https://doi.org/10.1159/000527041
319. Johnston, M. P., & Coward, D. D. (2001). Cancer-Related Fatigue: Nursing Assessment and Management. AJN American Journal of Nursing. https://doi.org/10.1097/00000446-200104001-00005
320. Jongsma, A. E., & Berghuis, D. J. (2001). The Child Psychotherapy Progress Notes Planner.
321. Jorge, T. P. C. (2012). Fisiopatología del dolor agudo: alteraciones cardiovasculares, respiratorias y de otros sistemas y órganos.
322. Joshi, S., & Kapur, J. (2012). GABAA Receptor Plasticity during Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199746545.003.0041
323. Juanes, R. G., Fuster, M. N. L., Gili, M., Bennasar, M. Á. R., & Toro, M. G. (2015). Estil de vida i salut mental. Anuari de l'envelliment: Illes Balears.
324. Judd, L. L., Rapaport, M. H., Paulus, M. P., & Brown, J. L. (1994). Subsyndromal symptomatic depression: a new mood disorder?. PubMed.
325. Juruena, M. F. (2012). Understanding subthreshold depression.. PubMed. https://doi.org/10.3969/j.issn.1002-0829.2012.05.009
326. Kalish, R. A. (2019). Death and Survivorship: The Final Transition. Routledge eBooks. https://doi.org/10.4324/9781315227085-6
327. Kanbara, K., & Fukunaga, M. (2009). Pathology of functional somatic syndrome.
328. Kandratavicius, L., Hallak, J., & Leite, J. P. (2007). Psicose e depressão na epilepsia do lobo temporal. Journal of Epilepsy and Clinical Neurophysiology. https://doi.org/10.1590/s1676-26492007000400004
329. Kap, Y. S. (2010). A Primate View on Multiple Sclerosis.
330. Kar, S. K., Ahmad, J., & Das, K. (2018). Understanding the correlates of manic episode in a woman with insular glioma. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_245_18
331. Kara, N. (2014). Cognitive Behavioral Therapy of a Generalized Anxiety Disorder Case Comorbid with Health Anxiety. Journal of Cognitive-Behavioral Psychotherapy and Research. https://doi.org/10.5455/jcbpr.158133
332. Karakuş, G., & Tamam, L. (2015). Obsesif Kompulsif ve İlişkili Bozukluklarda Özkıyım. Arşiv Kaynak Tarama Dergisi. https://doi.org/10.17827/aktd.57326
333. Karki, M., & Mahara, G. (2022). Heart Diseases, Anxiety Disorders, and Negative Thoughts. Heart and Mind. https://doi.org/10.4103/hm.hm_45_21
334. Karvonen, J. T., Läksy, K., & Räsänen, S. (2016). [Somatization disorder - an overdiagnosed but underestimated illness].. PubMed.
335. Katzman, M. A. (2021). The Diagnosis of Major Depressive Disorder is based on the Person's Reported Experiences and a Mental Status Examination. Journal of Aging and Geriatric Medicine.
336. Kaur, M. (2021). 4 tips for working with caregivers of children with somatic disorders. Current psychiatry. https://doi.org/10.12788/cp.0139
337. Kawa, K. (1992). [Chronic fatigue syndrome in school children].. PubMed.
338. Kellett, J. M. (1993). Long term care on the NHS: a vanishing prospect.. BMJ. https://doi.org/10.1136/bmj.306.6881.846
339. Kelly, F. D. (2010). Adjustment Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0015
340. Kemp, B., Bongartz, K., & Rath, W. (2003). Postpartale psychische Störungen - ein unterschätztes Problem in der Geburtshilfe. Zeitschrift für Geburtshilfe und Neonatologie. https://doi.org/10.1055/s-2003-43419
341. Kerssens, C. J., Pijnenburg, Y. A., Schouws, S., Eikelenboom, P., & Tilburg, W. V. (2006). [The development of psychotic symptoms in later life: late-onset schizophrenia or frontotemporal dementia? A case study].. PubMed.
342. Kessler, R. C., & Wang, P. S. (2008). The Descriptive Epidemiology of Commonly Occurring Mental Disorders in the United States. Annual Review of Public Health. https://doi.org/10.1146/annurev.publhealth.29.020907.090847
343. Khanam, S. (2017). Impact of Stress on Physiology of Endocrine System and on Immune System: A Review. International Journal of Diabetes and Endocrinology. https://doi.org/10.11648/j.ijde.20170203.12
344. Khare, S. (2021). The Impact of Chemical Changes in The Brain Caused by Chronic Stress Can Trigger Depression. International Journal of Indian Psychology. https://doi.org/10.25215/0904.032
345. Kiecolt‐Glaser, J. K., Renna, M. E., Shrout, M. R., & Madison, A. A. (2020). Stress Reactivity: What Pushes Us Higher, Faster, and Longer—and Why It Matters. Current Directions in Psychological Science. https://doi.org/10.1177/0963721420949521
346. Kim, Y. S. (2014). Physical Activity and Mental Health. Hanyang Medical Reviews. https://doi.org/10.7599/hmr.2014.34.2.60
347. Kissane, D. W., & Yates, P. (2018). Psychological and Existential Distress. Routledge eBooks. https://doi.org/10.4324/9781315378473-16
348. Kivelä, S., & Pahkala, K. (1988). Clinician-Rated Symptoms and Signs of Depression in Aged Finns. International Journal of Social Psychiatry. https://doi.org/10.1177/002076408803400405
349. Klein, D. F., & Wender, P. H. (2005). Symptoms of Mood Disorders: Recognizing Biological Depression. https://doi.org/10.1093/oso/9780195156133.003.0002
350. Klein, H. (1991). Couvade Syndrome: Male Counterpart to Pregnancy. The International Journal of Psychiatry in Medicine. https://doi.org/10.2190/fle0-92jm-c4cn-j83t
351. Knapen, J., Vancampfort, D., Schoubs, B., Probst, M.-T., Sienaert, P., Haake, P., Peuskens, J., & Pieters, G. (2009). Exercise for the Treatment of Depression. The Open Complementary Medicine Journal. https://doi.org/10.2174/1876391x00901010078
352. Kocsis, J. H., & Brody, B. D. (2013). Chronic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9781139175869.010
353. Koenig, A., DeLozier, I. J., Zmuda, M., Marron, M. M., Begley, A., Anderson, S., Reynolds, C. F., Arnold, S. E., Becker, J. T., & Butters, M. A. (2015). Neuropsychological Functioning in the Acute and Remitted States of Late-Life Depression. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-148006
354. Konieczka, K., Koch, S., Binggeli, T., Schoetzau, A., & Kesselring, J. (2016). Multiple sclerosis and primary vascular dysregulation (Flammer syndrome). The EPMA Journal. https://doi.org/10.1186/s13167-016-0062-6
355. Koo, B. B. (2011). Sleep-Related Movement Disorders. BENTHAM SCIENCE PUBLISHERS eBooks. https://doi.org/10.2174/978160805267711101010045
356. Koo, S. K. (2018). Depression Status in Korea. Osong Public Health and Research Perspectives. https://doi.org/10.24171/j.phrp.2018.9.4.01
357. Koponen, H., & Lappalainen, J. (2015). [Somatic health of a mental patient].. PubMed.
358. Koponen, H., Lepola, U., & Leìnonen, E. (1995). Recurrent brief depression: A review. Nordic Journal of Psychiatry. https://doi.org/10.3109/08039489509011882
359. Korff, M. V., & Simon, G. (1996). The Relationship Between Pain and Depression. The British Journal of Psychiatry. https://doi.org/10.1192/s0007125000298474
360. Korzekwa, M., & Steiner, M. (1997). Premenstrual Syndromes. Clinical Obstetrics & Gynecology. https://doi.org/10.1097/00003081-199709000-00017
361. Kot-Bryćko, K., & Pietraszkiewicz, F. (2021). Psychological Aspects of Ostaoarthritis. Polish Journal of Sports Medicine. https://doi.org/10.5604/01.3001.0014.8910
362. Kotade, K. B., Pandit, B. S., Gaware, V. M., Dolas, R. T., Dhamak, K. B., Somwanshi, S. B., Nikam, V. K., & Khadse, A. N. (2011). KNOWING DEPRESSION AND PHARMACOLOGICAL, NON-PHARMACOLOGICAL APPROACHES FOR ITS TREATMENT.
363. Koychev, I., & Ebmeier, K. P. (2016). Anxiety in older adults often goes undiagnosed.. PubMed.
364. Kozlowska, K., Scher, S., & Helgeland, H. (2020). The Stress-System Model for Functional Somatic Symptoms. Palgrave texts in counselling and psychotherapy. https://doi.org/10.1007/978-3-030-46184-3_4
365. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2006). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b21610-26
366. Krahn, L. E., MD, & Jowsey‐Gregoire, S. G. (2007). Psychiatry. CRC Press eBooks. https://doi.org/10.1201/b14442-26
367. Kral, V. A. (1973). Psychiatric problems in the aged: a reconsideration.. PubMed.
368. Krantz, D. S., Gabbay, F. H., Hedges, S. M., Leach, S., Gottdiener, J. S., & Rozanski, A. (1993). Mental and Physical Triggers of Silent Myocardial Ischemia: Ambulatory Studies Using Self-Monitoring Diary Methodology. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/15.1.33
369. Kroyzer, N., Hashkes, P. J., & Ben‐Pazi, H. (2015). Sydenham's chorea: Long-term immunosuppression for psychiatric symptoms. Journal of Pediatric Neurology. https://doi.org/10.3233/jpn-2012-0561
370. Krumholz, A., Sung, G., Fisher, R. S., Barry, E. F., Bergey, G. K., & Grattan, L. M. (1995). Complex partial status epilepticus accompanied by serious morbidity and mortality. Neurology. https://doi.org/10.1212/wnl.45.8.1499
371. Krystal, A. D., Edinger, J. D., & Wohlgemuth, W. K. (2013). Sleep and Circadian Rhythm Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt08
372. Kuman, M. (2018). Body Regulating Mechanisms in Health and Disease - Hormonal Imbalance and Mental Diseases. SOJ Immunology. https://doi.org/10.15226/2372-0948/6/3/00176
373. Kumar, G. P., Krishna, P. Y., Manisha, D., Singh, G., Khushboo, A., & Ps, M. (2015). ROLE OF MANAS BHAVA IN THE ETIOPATHOGENESIS OF AMLAPITTA IN CONTEXT OF HYPERACIDITY.
374. Kumar, R. (2001). Maternal Mental Illness and Severe Disorders of Mother-Child Attachment. Devenir.
375. Kučikienė, O., Lesauskaitė, V., Macijauskienė, J., Vainoras, A., Blaževičienė, A., Samėnienė, J., Alekna, V., Satkunskienė, D., Naudžiūnas, A., & Krutulytė, G. (2009). Dažniausi hospitalizuotų pagyvenusio amžiaus pacientų sveikatos sutrikimai.
376. Küstner, E. C., Cuéllar, H. C., & López, J. L. (2004). Introducción al síndrome de fatiga crónica (SFC). Archivos de odontoestomatología.
377. Laboudi, F., Korchi, A., & Ouanass, A. (2023). Comorbid anxiety has schizophrenia diagnosis and management modality. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2023.1421
378. Lalithaa, K., & Kathiravan, J. (2020). Effectiveness of homoeopathic medicines in illness anxiety disorders among young adults. International Journal of Homoeopathic Sciences. https://doi.org/10.33545/26164485.2020.v4.i2b.154
379. Lam, R. W. (2018). Associated clinical features. Depression. https://doi.org/10.1093/med/9780198804147.003.0005
380. Latta, F., & Cauter, E. V. (2003). Sleep and Biological Clocks. Handbook of Psychology. https://doi.org/10.1002/0471264385.wei0313
381. Lawrie, S. M. (2010). Schizophrenia, bipolar disorder, obsessive–compulsive disorder, and personality disorder. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260507
382. Lee‐Chiong, T. (2008). Restless Legs Syndrome and Periodic Limb Movement Disorder. https://doi.org/10.1093/oso/9780195306590.003.0008
383. LEHMAN, M., Foster, C., & Keul, J. (1993). Overtraining in endurance athletes: a brief review. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/00005768-199307000-00015
384. Leiblum, S. R., & Nathan, S. G. (2002). Persistent sexual arousal syndrome in women: A not uncommon but little recognized complaint. Sexual & Relationship Therapy. https://doi.org/10.1080/14681990220121301
385. Leifer, R. (1996). Psychological and Spiritual Factors in Chronic Illness. American Behavioral Scientist. https://doi.org/10.1177/0002764296039006010
386. Leithäuser, B., & Ladwig, K. (2019). Psychokardiologische Aspekte bei Vorhofflimmern. Ärztliche Psychotherapie.
387. Lembo, D., Prosperi, I., & Fabrizi, A. (2009). Una nuova disfunzione sessuale femminile: Il Disturbo da Eccitazione Sessuale Persistente (PSAD). RIVISTA DI SESSUOLOGIA CLINICA. https://doi.org/10.3280/rsc2009-002003
388. Lepping, P., Huber, M., & Freudenmann, R. W. (2015). How to approach delusional infestation. BMJ. https://doi.org/10.1136/bmj.h1328
389. Lečić-Toševski, D. M., Pejović-Milovančević, M., Popović-Deušić, S., & Šušić (2007). [Psychiatric aspects of sleep].. PubMed.
390. Lipsitz, L. A. (2004). Physiological Complexity, Aging, and the Path to Frailty. Science of Aging Knowledge Environment. https://doi.org/10.1126/sageke.2004.16.pe16
391. Lipton, R. B., & Silberstein, S. D. (2015). Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/head.12505_2
392. Lloyd, C. (1980). Life Events and Depressive Disorder Reviewed. Archives of General Psychiatry. https://doi.org/10.1001/archpsyc.1980.01780180055005
393. Lockwood, K. G., Peddie, L., Crosswell, A. D., Hives, B. A., Slopen, N., Almeida, D. M., & Puterman, E. (2022). Effects of Chronic Burden Across Multiple Domains and Experiences of Daily Stressors on Negative Affect. Annals of Behavioral Medicine. https://doi.org/10.1093/abm/kaac001
394. Loitman, J. E., & Deshields, T. L. (2010). Psychiatric Palliative Care Issues. Humana Press eBooks. https://doi.org/10.1007/978-1-60761-590-3_4
395. Lovas, J. (2015). Evidence-based relaxation therapy: 'Physiological and psychological benefits'. Journal of the Australian Traditional-Medicine Society.
396. Lucassen, P., Ockenburg, S. V., Gans, R. O. B., Rosmalen, J. G., & Hartman, T. O. (2022). [Fatigue].. PubMed.
397. Lucassen, P., Ockenburg, S. V., Gans, R. O. B., Rosmalen, J. G., & Hartman, T. O. (2024). [Fatigue].. PubMed.
398. Lucena, A. C. D. A., Lopes, E. D. A. N., Marinho, F. M. D. S., & Pelo, M. V. G. (2022). Fatores que influenciam para o desenvolvimento da depressão na gestação. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.1
399. Luijendijk, H. J. (2010). Vascular Heart and Brain Disease and Incident Late-Life Depression.
400. Lukito, P. M., & Wreksoatmodjo, B. R. (2024). Gangguan Neurologis Pasca-COVID-19. Cermin Dunia Kedokteran. https://doi.org/10.55175/cdk.v51i8.1532
401. Lundin, L., & Flyckt, L. (2015). [Schizophrenia past and present--the perception of long term prognoses have changed].. PubMed.
402. Lê, M. H., Nguyễn, V. B., & Nguyễn, T. B. T. (2024). ĐÁNH GIÁ HIỆU QUẢ CẢI THIỆN HỘI CHỨNG RỄ THẦN KINH CỦA PHÁC ĐỒ THUỐC THANG, ĐIỆN CHÂM, KÉO GIÃN CỘT SỐNG TRÊN BỆNH NHÂN CÓ HỘI CHỨNG CHÈN ÉP RỄ THẦN KINH ĐIỀU TRỊ NỘI TRÚ TẠI BỆNH VIỆN Y HỌC CỔ TRUYỀN CẦN THƠ. Tạp chí Y Dược học Cần Thơ. https://doi.org/10.58490/ctump.2024i71.2269
403. L�pine, J.-P., & Briley, M. (2004). The epidemiology of pain in depression. Human Psychopharmacology Clinical and Experimental. https://doi.org/10.1002/hup.618
404. M.Sc., D. A. V. S. D. R. (1989). Generalized anxiety disorder.. PubMed.
405. Mackenzie, I. S., & Brown, M. J. (2007). Pseudopheochromocytoma. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e3282f0fdbc
406. Macneil, C., Hasty, M., Conus, P., Berk, M., & Scott, J. (2009). Social rhythm regulation. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511757389.008
407. Macovei, A. L., Dobrin, I., Chiriță, V., Burlui, A., Dobrin, P.-R., & Rezuş, E. (2019). Chronic fatigue and psychiatric comorbidities in patients with rheumatic disorders. Bulletin of Integrative Psychiatry. https://doi.org/10.36219/bpi.2019.03.08
408. Madan, A., Frueh, B. C., Fowler, J. C., Stomberg, S., Bradshaw, M. R., Kelly, K. R., Weinstein, B., Luttrell, M., Danner, S. G., & Beidel, D. C. (2020). “Operator syndrome”: A unique constellation of medical and behavioral health-care needs of military special operation forces. The International Journal of Psychiatry in Medicine. https://doi.org/10.1177/0091217420906659
409. Madhavan, J. (2017). Ayurvedic Approach to Alcohol Withdrawal Syndrome. International Journal of Complementary & Alternative Medicine. https://doi.org/10.15406/ijcam.2017.07.00226
410. Madruga, M. L. L. H., Melo, G. B., Martins, J. M., Aranha, R. E. L. D. B., Marinho, J. C. R. L., Alves, N. T., Estudo, E., Revisão, U., & Literatura, D. (2018). Estudo Eletroencefalográfico De Indivíduos Com Dor Crônica Decorrente Da Fibromialgia: Uma Revisão Da Literatura. Scientific Research and Reviews. https://doi.org/10.28933/srr-2018-06-28100
411. Mahato, T. K., Ojha, S. K., Singh, V., & Parihar, S. P. S. (2021). Addiction withdrawal syndrome: Needs medications, education, counselling &amp; support. World Journal of Advanced Research and Reviews. https://doi.org/10.30574/wjarr.2021.12.2.0573
412. Mahon, K., Arnold, R. W., & Koller, H. P. (2007). Symptomatic Convergence Insufficiency. Journal of Pediatric Ophthalmology & Strabismus. https://doi.org/10.3928/01913913-20070701-12
413. Mahon, S. M., & Carr, E. (2021). Fatigue/Lack of Endurance: Common Side Effect. Clinical journal of oncology nursing. https://doi.org/10.1188/21.cjon.s2.25
414. Maier, W., & Falkai, P. (1999). The epidemiology of comorbidity between depression, anxiety disorders and somatic diseases.. PubMed.
415. Malhotra, B. S., Nain, P., Sidana, J., Gupta, A., & Sharma, S. (2011). Chronic Fatigue Syndrome: A Review. HAL (Le Centre pour la Communication Scientifique Directe).
416. Malsert, J., & Lejeune, F. (2015). Les troubles dépressifs maternels: conséquences sur le développement neurocognitif et affectif du jeune enfant. Médecine & enfance.
417. Mandoki, M. (1994). Buspirone Treatment of Traumatic Brain Injury in a Child Who Is Highly Sensitive to Adverse Effects of Psychotropic Medications. Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/cap.1994.4.129
418. Mandos, L. A., PharmD, Reinhold, J. A., Bcps, Bcpp, & Rickels, K. (2009). Achieving Remission in Generalized Anxiety Disorder.
419. Manford, M., & Shorvon, S. (1992). Prolonged sensory or visceral symptoms: an under-diagnosed form of non-convulsive focal (simple partial) status epilepticus.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.55.8.714
420. Manfredini, R., Cecilia, L., Boari, B., & Gallerani, M. (2001). [Epistaxis and circadian rhythm].. PubMed.
421. Manica, A., Leães, C. G. S., Frey, B. N., & Juruena, M. F. (1999). The role of depression in coronary artery disease. Arquivos Brasileiros de Cardiologia. https://doi.org/10.1590/s0066-782x1999000800012
422. Manysheva, K., Sherman, M. A., Zhukova, N. V., & Kopishinskaia, S. (2022). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: First Described Complication after Gam-COVID-Vac Vaccine.. PubMed.
423. Maramis, M. M. (2009). Mengenal Gangguan Mood pada Perempuan.
424. Mariano, E. E., Santos, A. J. C. D., Barbosa, G. H. D. S., Cardoso, É. C. J., Penha, L. F., Batista, I. P. B., Mendonça, R. F. D., Dupim, I. B. D. F., Martins, I. D. O., Morais, A. C. D. S., & Silva, A. L. P. D. (2023). DEPRESSION IN THE ELDERLY: THE INFLUENCE OF THE AGING PROCESS IN THE DEVELOPMENT OF DEPRESSION. International Journal of Health Science. https://doi.org/10.22533/at.ed.1593552320077
425. Mario, S., & Sevilla, A. R. (2019). Estrés diario y calidad de vida en las personas con lesión medular espinal.
426. Markham, R. A., & Watts, S. (2005). Etiology of Depression in Children.. Journal of instructional psychology.
427. Martin, K. A. (2021). Miscellaneous Psychiatric Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197512166.003.0043
428. Martin, P., & Poon, L. W. (2015). Exceptional Survivors. The Encyclopedia of Adulthood and Aging. https://doi.org/10.1002/9781118521373.wbeaa073
429. Mateen, Y., Lally, J., & Bokhari, S. Q. (2022). Chronic, Unipolar, Treatment-Resistant Mania: A Case Report and Literature Review. BJPsych Open. https://doi.org/10.1192/bjo.2022.363
430. Mateus, L. A. S. (2022). Games violentos e sua relação com comportamento social das crianças. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.19
431. Matta, M. (2010). Mental Health Matters.
432. Mayor, K., Talmon, Y., Guy, N., Raps, A., & Naor, S. (1992). ["Saddam syndrome:" acute psychotic reactions during the Gulf War--renewal of concept of brief reactive psychosis].. PubMed.
433. Mayou, R., & Sharpe, M. (1997). Treating medically unexplained physical symptoms. BMJ. https://doi.org/10.1136/bmj.315.7108.561
434. Mazumdar, H., Haloi, N., & Mazumdar, M. (2011). Impact of job stress on urban and rural employees in Kamrup district, Assam (India): A physiological and psychological study.. Archives of applied science research.
435. McDanielp, P. W. (2018). A possible link between circadian rhythm disorders and mood disorders. Journal of Neuropsychopharmacology & Mental Health.
436. McGhie-Fraser, B., Ballering, A., Lucassen, P., McLoughlin, C., Brouwers, E., Stone, J., Hartman, T. O., & Dulmen, S. V. (2024). Validation of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP). Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2024.111505
437. McGhie-Fraser, B., McLoughlin, C., Lucassen, P., Ballering, A., Dulmen, S. V., Brouwers, E., Stone, J., & Hartman, T. O. (2024). Measuring persistent somatic symptom related stigmatisation: Development of the Persistent Somatic Symptom Stigma scale for Healthcare Professionals (PSSS-HCP). Journal of Psychosomatic Research. https://doi.org/10.1016/j.jpsychores.2024.111689
438. McKnight, R., Price, J., & Geddes, J. (2019). People presenting with physical disorder. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780198754008.003.0027
439. McNaughton, N., & Corr, P. J. (2016). Mechanisms of comorbidity, continuity, and discontinuity in anxiety-related disorders. Development and Psychopathology. https://doi.org/10.1017/s0954579416000699
440. Meade, E., & Garvey, M. (2022). The Role of Neuro-Immune Interaction in Chronic Pain Conditions; Functional Somatic Syndrome, Neurogenic Inflammation, and Peripheral Neuropathy. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms23158574
441. Medina, A. B., Roniger, D. D. G., Alonzo, G. M., & Genchi, A. J. (2012). Síndrome de piernas inquietas en comorbilidad con trastornos psiquiátricos y enfermedad médica: un caso ilustrativo. Psiquis - Hospital Psiquiátrico Fray Bernardino Alvarez.
442. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). [Clinical practice guideline. Diagnosis and treatment of insomnia in the elderly].. PubMed.
443. Medina-Chávez, J. H., Fuentes-Alexandro, S., Gil-Palafox, I. B., Adame-Galván, L., Solís-Lam, F., Sánchez-Herrera, L. Y., & Narváez, F. S. (2014). Diagnóstico y tratamiento del insomnio en el adulto mayor.
444. Meeks, L. M., & Jain, N. R. (2018). Accommodating chronic health conditions in medical education. Disability Compliance for Higher Education. https://doi.org/10.1002/dhe.30432
445. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo Obesity and mental disorders: building an effective care.
446. Melca, I. A., & Fortes, S. (2014). Obesidade e transtornos mentais: construindo um cuidado efetivo. Revista Hospital Universitário Pedro Ernesto. https://doi.org/10.12957/rhupe.2014.9794
447. Menefee, D. S., Ledoux, T., & Johnston, C. A. (2022). The Importance of Emotional Regulation in Mental Health. American Journal of Lifestyle Medicine. https://doi.org/10.1177/15598276211049771
448. Merlo, G., Nikbin, A., & Ryu, H. (2021). Emotional Wellness and Stress Resilience. CRC Press eBooks. https://doi.org/10.1201/9781003110682-5
449. Mewes, R., & Rief, W. (2008). Somatoforme Störungen und Hypochondrie. Psychiatrie und Psychotherapie up2date. https://doi.org/10.1055/s-2007-986338
450. Miller, L. C. (2004). Effects Of Stress In Early Life. https://doi.org/10.1093/oso/9780195176810.003.0008
451. Mills, S. (2015). Chronic low back pain. InnovAiT Education and inspiration for general practice. https://doi.org/10.1177/1755738015579209
452. Mir, J. A., Mushtaq, B., & Mushtaq, O. A. (2022). Clinical case report on bipolar affective disorder, mania. IP Journal of Paediatrics and Nursing Science. https://doi.org/10.18231/j.ijpns.2022.007
453. Miyajima, K., & Fujisawa, D. (2017). Psychological distress in cancer patients and family caregivers. Stress Science Research. https://doi.org/10.5058/stresskagakukenkyu.2017007
454. Mohamed, A. A. A., Zaki, M. M., & Mahmoud, D. A. B. (2022). Relationship between Quality of Life and Sleep Habits in Children with Attention Deficit Hyperactivity Disorder. Journal of Nursing Science Benha University/Journal of Nursing Science Benha University . https://doi.org/10.21608/jnsbu.2023.274558
455. Molière, F. (2014). Comorbidités psychiatriques et résistance thérapeutique. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2014.09.052
456. Montejo, Á. L., Montejo, L., & Baldwin, D. S. (2018). The impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management. World Psychiatry. https://doi.org/10.1002/wps.20509
457. Montgomery, S., Bebbington, P., Cowen, P. J., Deakin, J., Freeling, P., Hallström, C., Katona, C., King, D. S., Leonard, B., Levine, S., Phanjoo, A. L., Peet, M., Thompson, C. M., & Thompson, C. M. (1993). Guidelines for treating depressive illness with antidepressants: A statement from the British Association for Psychopharmacology. Journal of Psychopharmacology. https://doi.org/10.1177/0269881193007001041
458. Moore, N. C., LeWitt, P. A., & Gershon, S. (1992). Reduction of dyskinesias and psychiatric disability with clozapine over different time courses. Journal of Psychopharmacology. https://doi.org/10.1177/026988119200600407
459. Moret, C., Isaac, M., & Briley, M. (2008). Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors. Journal of Psychopharmacology. https://doi.org/10.1177/0269881108093582
460. Morgan, R. O., Pendleton, N., Clague, J., & Horan, M. (1997). Older people's perceptions about symptoms.. PubMed.
461. Morin, C. M., & Edinger, J. D. (2008). Sleep/Wake Disorders. https://doi.org/10.1093/oso/9780195374216.003.0019
462. Morris, T. L. (2004). Diagnosis of Social Anxiety Disorder in Children. CRC Press eBooks. https://doi.org/10.3109/9780203026106-12
463. Mossaheb, N., Schloegelhofer, M., Schaefer, M., Fusar‐Poli, P., Smesny, S., McGorry, P. D., Berger, G., & Amminger, G. P. (2012). Long-Chain Omega-3 Fatty Acids and Psychotic Disorders. Humana Press eBooks. https://doi.org/10.1007/978-1-62703-215-5_9
464. Mott, T., McConnon, M. L., & Rieger, B. (2012). Subacute to chronic mild traumatic brain injury.. PubMed.
465. Moyo⃰, G. P. K. (2020). Perinatality and Childbirth as a Factor of Decompensation of Mental Illness: The Case of Depressive States in Newly Delivered Cameroonian Women. Archives in Biomedical Engineering & Biotechnology. https://doi.org/10.33552/abeb.2020.04.000592
466. Mucci, V., Sussetto, M., Ranieri, M., Cavuscens, S., Fornos, A. P., & Guinand, N. (2019). [The Mal de Débarquement Syndrome].. PubMed.
467. Munir, S., & Takov, V. (2021). Generalized Anxiety Disorder. StatPearls.
468. Munir, S., Takov, V., & Coletti, V. A. (2021). Generalized Anxiety Disorder (Nursing).
469. Murakami, M., & Matsuno, T. (2010). Musculoskeletal Chronic Pain and Psychosocial Stress. Journal of Nihon University Medical Association. https://doi.org/10.4264/numa.69.183
470. Murray, R. B. (1996). Stressors and Coping Strategies of Homeless Men. Journal of Psychosocial Nursing and Mental Health Services. https://doi.org/10.3928/0279-3695-19960801-13
471. Mut, E. A., Pălădoiu, C., & Stănescu, M. (2021). Somatoform and conversion disorders as psychological defences. Journal of Educational Sciences & Psychology. https://doi.org/10.51865/jesp.2021.1.19
472. Muñoz-Lara, J. (2015). Depresión en la persona adulta mayor institucionalizada: Un nuevo reto. Revista Hispanoamericana de Ciencias de la Salud (RHCS).
473. Müller‐Spahn, F., & Hock, C. (1994). Clinical Presentation of Depression in the Elderly. Gerontology. https://doi.org/10.1159/000213615
474. Na, Y.-N. (2021). A Psychoanalytic Study on the Abnormal Behavior of Muzong emperor in Liao Dynasty. JOURNAL OF ASIAN HISTORICAL STUDIES. https://doi.org/10.17856/jahs.2021.3.154.75
475. Naeim, M. (2021). How to control stress caused by COVID-19?. Healthy Aging Research.
476. Nafiaa, H., Benchikhi, L., & Ouanass, A. (2022). Morphological Abnormalities in Schizophrenia: Systematic Review. SAS Journal of Medicine. https://doi.org/10.36347/sasjm.2022.v08i05.005
477. Nandi, K., Sarkar, S., Bakshi, P., Chandra, A. C., Chakraborty, A., Mondal, S., Biswas, A., Bera, K., Sen, D. J., & Saha, D. (2005). COVID-19 & CO-MORBIDITY: DEMONIC FORCES THAT SUPRESS THE CIVILIZATION. World Journal of Pharmaceutical and life sciences.
478. Nasirabadi, M., Ali, M., & Vaseem, A. (2021). Empowering Practitioners in Helping Patients with Common Mental Health Issues. https://doi.org/10.52314/tjima.2021.v1i2.35
479. Nava, G. M. (2018). Depression: From Sorrow to Melancholia. Scholarly Journal of Psychology and Behavioral Sciences. https://doi.org/10.32474/sjpbs.2018.01.000106
480. Ngo, T. L., & Doughty, C. (2010). Progressive Unilateral Arm Weakness in a 7-Year-Old Boy. Pediatric Emergency Care. https://doi.org/10.1097/pec.0b013e3181f054e6
481. Nicolas, I. (2008). [Long-term evolution and complications of eating disorders].. La Revue du praticien.
482. Nicolson, G. L., Nasralla, M. Y., Haier, J., & Nicolson, N. L. (1999). GULF WAR ILLNESSES: ROLE OF CHEMICAL, RADIOLOGICAL AND BIOLOGICAL EXPOSURES.
483. Nielsen, J. F., Klemar, B., Hansen, H., & Sinkjær, T. (1995). A new treatment of spasticity with repetitive magnetic stimulation in multiple sclerosis.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.58.2.254-a
484. Nindela, R., Prananjaya, B. A., & Fatimah, N. (2022). Peningkatan pemahaman masyarakat tentang nyeri muskuloskeletal kronik dari aspek neuropsikorehabilitatif. Jurnal Pengabdian Masyarakat Humanity and Medicine. https://doi.org/10.32539/hummed.v3i3.90
485. Nishino, S., & Fujiki, N. (2006). Animal models for sleep disorders. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511541742.029
486. Nizamie, A., Sengupta, U., Mishra, B. R., Praharaj, S. K., & Nizamie, S. H. (2010). Alka Nizamie;Uma Sengupta;Biswa Ranjan Mishra;Samir Kumar Praharaj;S. Haque Nizamie. Acta Neurologica Taiwanica. https://doi.org/10.29819/ant.201003.0008
487. Noctor, E., Kennedy, K., & Corby, C. S. (2020). Manic-like presentation with an organic aetiology. Irish Journal of Psychological Medicine. https://doi.org/10.1017/ipm.2020.76
488. Novati, A. (2012). Sleep loss, brain vulnerability and psychopathology: experimental studies on the neurobiological consequences of chronic sleep restriction in rats.
489. Novák, M. (2010). S27-04 - Sleep Disorders, Mental Health and Quality of Life. European Psychiatry. https://doi.org/10.1016/s0924-9338(10)70094-8
490. Noyes, R. (2014). Course and Outcome of Hypochondriasis and Health Anxiety. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199996865.003.0007
491. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. American Journal of Biomedical Science & Research. https://doi.org/10.34297/ajbsr.2022.16.002239
492. Ntchana, A. (2022). A Case of Brief Psychotic Disorder: An Unintended Consequence of COVID-19 Virus. Psychology & Psychological Research International Journal. https://doi.org/10.23880/pprij-16000300
493. Oates, L. (2010). Complementary medicines for anxiety. Australian pharmacist.
494. Oh, S.-H. (2019). 12 - CAN RORSCHACH DIFFERENTIATE BIPOLAR DISORDER FROM DEPRESSIVE DISORDER? : COMPARISON OF RORSCHACH SCORES BETWEEN BIPOAR DEPRESSION AND UNIPOLAR DEPRESSION. https://doi.org/10.26226/morressier.5d1a038757558b317a13f97e
495. OIu, S., & Mv, R. (2008). [Social-psychological problems and their solution in anesthesiologists-resuscitators with different length of professional work]..
496. Ojha, A., & Kumar, D. (2021). Psychological Factors in Fibromyalgia and Chronic Fatigue Syndrome: Implications in Counseling. https://doi.org/10.56173/bjcp.2021.1102
497. Os, J. V., Praag, H. M. V., & Kloet, E. R. D. (2004). Stress, the brain and depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544422.010
498. Otsuka, K., Kato, S., Abe, T., SUGIYAMA, H., Watanabe, Y., Kobayashi, T., & Okajima, Y. (2002). [Classification of long-term clinical course of 'atypical psychosis': a 20-year follow-up study at a medical school hospital].. PubMed.
499. Otto, D. A., Hudnell, H. K., & Prah, J. D. (1992). Methodological Issues in Human Exposure Studies of Low Level Solvent Mixtures. Applied Psychology. https://doi.org/10.1111/j.1464-0597.1992.tb00702.x
500. Ouaghlani, K., Drissa, M., Othmen, R. B., Msaad, H., Hakim, K., & Ouarda, F. (2024). The yield of 24-hour ambulatory electrocardiography in the assessment of symptomatic school-age children.. PubMed.
501. Ozdemir, D., & Sahni, S. (2019). Conversion Disorder (Functional Neurological Symptom Disorder) Masquerading as Multiple Sclerosis: A Case Report. Cureus. https://doi.org/10.7759/cureus.4893
502. O’Dwyer, A.-M., & Campion, M. (2022). Psychiatry of later life. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198867135.003.0011
503. O’Neil-Page, E., Anderson, P. R., & Dean, G. E. (2015). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190244330.003.0001
504. O’Neil-Page, E., Dean, G. E., & Anderson, P. R. (2019). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862374.003.0010
505. Pablo, G. S. D. (2018). Mental Capacity and Decision Making in Bipolar Disorder. Peer Reviewed Journal of Forensic & Genetic Sciences. https://doi.org/10.32474/prjfgs.2018.03.000152
506. Pang, K. H., & Ahmedzai, S. H. (2021). Pain. CRC Press eBooks. https://doi.org/10.1201/9780429285813-14
507. Paolini, C. A. (2001). Symptoms management at the end of life.. PubMed.
508. Paredes, D. F. D., Farfán, J. C. P., Orellana, J. M. F., & Legarda, A. A. B. (2019). Trastorno disfórico premenstrual. RECIAMUC. https://doi.org/10.26820/reciamuc/3.(1).enero.2019.199-217
509. Pareek, A., & Verma, K. (2017). Effect of Yoga in Management of Chronic Pain.
510. PARISER, S. F., Nasrallah, H. A., & Gardner, D. L. (1997). Postpartum Mood Disorders: Clinical Perspectives. Journal of women's health. https://doi.org/10.1089/jwh.1997.6.421
511. Parker, G., & Manicavasagar, V. (2005). Anxious worrying and non-melancholic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.019
512. Parker, G., & Manicavasagar, V. (2005). Chronic stress-related non-melancholic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544194.016
513. Parmet, S., Burke, A. E., & Glass, R. M. (2006). Insomnia. JAMA. https://doi.org/10.1001/jama.295.24.2952
514. patil, A. J. (2017). Role of satvavajaya chikitsa in jara with special reference to socio-psychological problems. Journal of Ayurveda and Holistic Medicine.
515. Paulig, M. (2006). Multiple Sklerose: Fatigue. Nervenheilkunde. https://doi.org/10.1055/s-0038-1626815
516. Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995). Residual symptoms after partial remission: an important outcome in depression. Psychological Medicine. https://doi.org/10.1017/s0033291700033146
517. Pearce, J., & Carney, S. (2010). Enjoying the Golden Years: Diagnosing and Treating Depression. https://doi.org/10.1002/9781118281796.ch8
518. Pennebaker, J. W. (1994). Psychological Bases of Symptom Reporting: Perceptual and Emotional Aspects of Chemical Sensitivity. Toxicology and Industrial Health. https://doi.org/10.1177/074823379401000519
519. Pennebaker, J. W., & Chung, C. K. (2006). Expressive Writing, Emotional Upheavals, and Health. https://doi.org/10.1093/oso/9780195139594.003.0011
520. Pentin, P. L., & Sperry, L. D. (2015). Somatoform Disorders and Related Syndromes. Family Medicine. https://doi.org/10.1007/978-1-4939-0779-3_35-1
521. Pentin, P. L., & Sperry, L. D. (2016). Somatoform Disorders and Related Syndromes. Family Medicine. https://doi.org/10.1007/978-3-319-04414-9_35
522. Pereira, J. A. (2021). Teenager with paranoia and hallucinations preceded by a decline in academic and social functioning. Oxford University Press eBooks. https://doi.org/10.1093/med/9780197577479.003.0006
523. Pereira, J. V., & Araújo, G. D. F. (2024). Depressão puerperal e seu difícil diagnóstico. Jornal Brasileiro de Ginecologia. https://doi.org/10.5327/jbg-2965-3711-2024134s1235
524. Perrino, C. D. D. (2009). Prevalencia de síntomas afectivos en una cohorte de pacientes con trastorno bipolar: Un estudio de seguimiento prospectivo hasta 18 meses.
525. Petermann, F. (2012). Beschwerdenvalidierung. Die Rehabilitation. https://doi.org/10.1055/s-0032-1323652
526. Peyre, H., & Viorrain, M. (2018). [Pediatric Somatic Symptom Disorders].. PubMed.
527. Peña, D. A., Pérez, M. L., & Pinzón, L. F. C. (2014). Línea de investigación psicología clínica y de la salud..
528. Pigarova, E., & Rozhinskaya, L. Y. (2010). Sindrom khronicheskoy ustalosti: sovremennye predstavleniya ob etiologii. Obesity and metabolism. https://doi.org/10.14341/2071-8713-4977
529. Pitchot, W., Scantamburlo, G., Pinto, E., & Ansseau, M. (2007). [Discontinuation syndrome associated with antidepressants].. RMLG. Revue médicale de Liège.
530. Pizov, A. V. (2024). Mental fatigue and chronic fatigue syndrome in clinical practice. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/ms2024-150
531. Polack, R. G., Siemer, M., & Joormann, J. (2024). Sadness and Depression. Routledge eBooks. https://doi.org/10.4324/9781003469018-21
532. Politis, M., Wu, K., Molloy, S., Bain, P. G., Chaudhuri, К. R., & Piccini, P. (2010). Parkinson's disease symptoms: The patient's perspective. Movement Disorders. https://doi.org/10.1002/mds.23135
533. Popa, M.-S. (2009). Domestic Violence and its Consequences on Health. Management in Health. https://doi.org/10.5233/mih.v13i3.28
534. Potter, W. Z., & Goldstein, D. (2004). Biological Theories of Depression and Implications for Current and New Treatments. Humana Press eBooks. https://doi.org/10.1007/978-1-59259-792-5_1
535. Prasetya, E. C., Subagyo, R., Mahyuddin, M. H., Haniifah, U., Rafida, M., Hamida, A., Ramzy, M., & Prasetya, M. T. (2022). Continuously Paranoid Schizophrenia in Young Man: A Case Report. Asian Australasian Neuro and Health Science Journal (AANHS-J). https://doi.org/10.32734/aanhsj.v4i2.9165
536. Praško, J., Kovacsova, A., Jelenová, D., & Látalová, K. (2010). Chronic fatigue syndrom and its treatment - psychiatric view.
537. Priyadarshini, J. (2017). Depression-Let’s Talk. JOJ Nursing & Health Care. https://doi.org/10.19080/jojnhc.2017.01.555570
538. Prvčić, I., Zec, M. R., & Barišić, I. (2008). Psychological aspects of learning disabilities. Paediatria Croatica. https://doi.org/10.13112/pc.925
539. Puchkova, A. N. (2021). Sleep as a biological rhythm: clinical aspects. Meditsinskiy sovet = Medical Council. https://doi.org/10.21518/2079-701x-2021-2-56-61
540. Pueyo, J. O. (2019). Estados postdepresivos: Relevancia clínica de la depresión subsindrómica en los mayores. Informaciones psiquiátricas: Publicación científica de los Centros de la Congregación de Hermanas Hospitalarias del Sagrado Corazón de Jesús.
541. Pujalte, G. G., & Benjamin, H. J. (2018). Sleep and the Athlete. Current Sports Medicine Reports. https://doi.org/10.1249/jsr.0000000000000468
542. Putriana, M. M. G., Soetjipto, S., Margono, H. M., Santoso, C. M. A., & Kristiano, B. (2022). Music Therapy for Chronically ill Patient. Jurnal Psikiatri Surabaya. https://doi.org/10.20473/jps.v11i1.23379
543. Pérez, P. S. (2015). El déficit cognitivo en el síndrome de fatiga crónica: factores asociados y evolución.
544. Pérez, Y. M. M., Ortega, D. L. G., & Torres, S. V. L. (2022). AGITACIÓN PSICOMOTRIZ. PUERTO MADERO EDITORIAL eBooks. https://doi.org/10.55204/pmea.3.c10
545. Quintero, J. M. B., Castellanos, A., & Santos, L. S. D. L. (2018). Efectividad de una intervención pre-quirúrgica de enfermería; en ansiedad de pacientes sometidos a colecistectomía del Hospital General Regional No.1 Vicente Guerrero de Acapulco, 2017.
546. Qureshi, M. A., & Wasti, S. A. (2014). Lay-off Survivor Sickness Syndrome (Investigating the Lasting Impact on Performance of Survivors in the Context of Age and Gender in Private Sector Organizations of Pakistan). International Journal of Human Resource Studies. https://doi.org/10.5296/ijhrs.v4i3.6078
547. Rabins, P. V., & Slavney, P. R. (2008). Overview of Psychiatric Symptoms and Syndromes. Oxford University Press eBooks. https://doi.org/10.1093/oso/9780195309430.003.0008
548. Racciatti, D., Barberio, A., Vecchiet, J., & Pizzigallo, E. (1999). Clinical and Pathogenetical Characterization of 238 Patients of a Chronic Fatigue Syndrome Italian Center. Journal of Chronic Fatigue Syndrome. https://doi.org/10.1300/j092v05n03_05
549. Radulović, N., Mišković, M., Zoric, D., Maglov, T., & Ilić, D. (2008). Crisis intervention. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2008.01.569
550. Rakofsky, J. J., & Dunlop, B. W. (2014). Treating Bipolar Mania in the Outpatient Setting: Enlist the Help of Family, Employ Evidence-Based Pharmacologic and Psychotherapeutic Strategies. Current psychiatry.
551. Ramachandran, R., Leong, A. C., Varughese, S. M., & Goh, L. G. (2021). Chronic Fatigue Syndrome in Childhood Revisited: Not Common, But Not Unknown- Case Study and Literature Review. Research Square (Research Square). https://doi.org/10.21203/rs.3.rs-962672/v1
552. Ramos, S. B. (1986). Psicología Comunitaria en Atención Primaria de Salud: la experiencia del Síndrome Tóxico.. DOAJ (DOAJ: Directory of Open Access Journals).
553. Rani, S., & Saini, D. S. (2015). Organizational Stress in Relation to Job Satisfaction and General Health of Professional Women. International journal of education and management studies.
554. Rao, T. S. (2018). Psychosocial therapies in addictive disorders. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.224346
555. Rao, T. S., & Kumar, M. A. (2008). Agenda for specialty section in addiction medicine. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.44741
556. Rasmussen, N. H., & Avant, R. F. (1989). Somatization disorder in family practice.. PubMed.
557. Rathbone, A. L., & Prescott, J. (2019). Pregnancy-specific health anxiety: symptom or diagnosis?. British Journal of Midwifery. https://doi.org/10.12968/bjom.2019.27.5.288
558. Rathee, S. (2019). Psychosocial management of bipolar affective disorder. International Journal of Indian Psychology. https://doi.org/10.25215/0704.048
559. Rauh, E., & Rief, W. (2024). Ratgeber Somatoforme Beschwerden und Krankheitsängste. https://doi.org/10.1026/03290-000
560. Ravindran, A., & Ravindran, L. N. (2012). Tips for Treating Comorbid Depression and Anxiety.
561. Ray, C., Jeffefues, S., Weir, W., Hayes, K., Simon, S., Akingbade, F., & Marriott, P. (1998). Making sense of chronic fatigue syndrome: Patients' accounts of onset. Psychology and Health. https://doi.org/10.1080/08870449808406134
562. Rengel, K. F., Hayhurst, C. J., Pandharipande, P. P., & Hughes, C. G. (2019). Long-term Cognitive and Functional Impairments After Critical Illness. Anesthesia & Analgesia. https://doi.org/10.1213/ane.0000000000004066
563. Resch, M. (2010). The psychological factors affecting athletic performance. Orvosi Hetilap. https://doi.org/10.1556/oh.2010.28890
564. Rey, B., Sm, G., & Dp, C. (1992). Some neurovegetative correlates of Minnesota Multiphasic Personality Inventory (MMPI). Acta physiologica, pharmacologica et therapeutica latinoamericana : organo de la Asociacion Latinoamericana de Ciencias Fisiologicas y [de] la Asociacion Latinoamericana de Farmacologia.
565. Reyes, H. (2007). The worst scars are in the mind: psychological torture. International Review of the Red Cross. https://doi.org/10.1017/s1816383107001300
566. Reyes, P. O. (2019). La calidad de vida de los pacientes con dolor crónico y criterios de fragilidad en atención primaria. NURE investigación: Revista Científica de enfermería.
567. Rhenen, W. V., Roelen, C. A. M., Koopmans, P. C., Bültmann, U., Groothoff, J. W., & Klink, J. J. L. V. D. (2012). Sickness absence due to mental health disorders--a societal perspective. Occupational Medicine. https://doi.org/10.1093/occmed/kqs065
568. Ribeiro, B. M. D. S. S., Ribeiro, Â., Ribeiro, J., & Doellinger, O. V. (2013). 1214 – Emptiness in a life full of experiences: major depression in a 66-year-old man. European Psychiatry. https://doi.org/10.1016/s0924-9338(13)76295-3
569. Rickelt, J. (2022). Affecting OCD. https://doi.org/10.26481/dis.20221215jr
570. RIED, L. M. (2018). RELAÇÃO ENTRE A DEPRESSÃO E A DEMÊNCIA DO TIPO ALZHEIMER. https://doi.org/10.17771/pucrio.acad.36288
571. Roberts, A. R., & Yeager, K. R. (2009). Indicators of a Crisis-Prone Person. https://doi.org/10.1093/oso/9780195382907.003.0004
572. Roberts, A. R., & Yeager, K. R. (2009). Psychophysiological Reactions to a Crisis. https://doi.org/10.1093/oso/9780195382907.003.0007
573. Robinson, C. P., & Hocker, S. E. (2019). Status Epilepticus. Oxford University Press eBooks. https://doi.org/10.1093/med/9780190862923.003.0098
574. Rocha, S. A. R., Ferreira, C. R., Bertussi, V. C., Medeiros, R. M. P., Corrêa, L. U. D. L. A., Santos, S. R. D., Silva, L. R. F., Júnior, L. N. M., & TEIXEIRA, L. T. (2024). Saúde mental no puerpério: psicose, depressão e bayblues. Caderno Pedagógico. https://doi.org/10.54033/cadpedv21n3-211
575. Rodas, P. A. V., & Pena, M. (2024). Prevalência da alteração de capacidade funcional, síndrome de fragilidade e sarcopenia em pacientes com mais de 60 anos atendidos na Associação Fluminense de Reabilitação. Acta Fisiátrica. https://doi.org/10.11606/issn.2317-0190.v31isupl.1a225105
576. Rodriguez, C. P., Dodds, T., & Suzuki, J. (2017). Addiction. Pain Medicine. https://doi.org/10.1007/978-3-319-43133-8_33
577. Roelcke, U. (2001). Pathophysiology of fatigue in multiple sclerosis. CRC Press eBooks. https://doi.org/10.3109/9780203212974-27
578. Rogers, N. L., & Kloss, J. D. (2004). Medical Conditions and Diseases. CRC Press eBooks. https://doi.org/10.3109/9780203998007-6
579. Rollnik, J. D. (2017). Das chronische Müdigkeitssyndrom – ein kritischer Diskurs. Fortschritte der Neurologie · Psychiatrie. https://doi.org/10.1055/s-0042-121259
580. Romaniv, O., & Pohoriliak, K. (2017). Сlinical case: social load is the predictor and preventer of somatization. Psychosomatic Medicine and General Practice. https://doi.org/10.26766/pmgp.v2i2.28
581. Ronad, S. V., Patail, C. S., Gondbal, S. H., TC, K., Ronad, M., Pankaja, T., Badesgol, R., & Singhal, P. K. J. (2019). Professionals in metro cities suffer from anxiety disorder. Nursing & Care Open Access Journal. https://doi.org/10.15406/ncoaj.2019.06.00198
582. Ronco, C., McCullough, P. A., Anker, S. D., Anand, I. S., Aspromonte, N., Bagshaw, S. M., Bellomo, R., Berl, T., Bobek, I., Cruz, D. N., Daliento, L., Davenport, A., Haapio, M., Hillege, H. L., House, A. A., Katz, N., Maisel, A. S., Mankad, S., Zanco, P., ... Ponikowski, P. (2010). Cardiorenal Syndromes: An Executive Summary from the Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Contributions to nephrology. https://doi.org/10.1159/000313745
583. Rosenkranz, R. R., Neuendorf, C. M., Rosenkranz, S. K., & Sauer, K. (2020). Just Sit Still and Pay Attention?—A Commentary. Journal of School Health. https://doi.org/10.1111/josh.12881
584. Rosmalen, J. G., & Wenning, H. (2017). SOLK: POH-GGZ.
585. Rossignol, M. (2008). Expressions faciales émotionnelles et biais émotionnels dans les troubles dépressifs et anxieux.
586. Rosso, M. D., & Gaglio, P. (2008). Síndrome de fatiga crónica. Evidencia actualizacion en la práctica ambulatoria. https://doi.org/10.51987/evidencia.v11i1.5946
587. Rowe, P. C., Underhill, R., Friedman, K. J., Gurwitt, A., Medow, M. S., Schwartz, M., Speight, N., Stewart, J. M., Vallings, R., & Rowe, K. S. (2017). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Diagnosis and Management in Young People: A Primer. Frontiers in Pediatrics. https://doi.org/10.3389/fped.2017.00121
588. Roy, A. (1996). Aetiology of Secondary Depression in Male Alcoholics. The British Journal of Psychiatry. https://doi.org/10.1192/bjp.169.6.753
589. Rudolf, G. A. E. (2000). Diagnostische und therapeutische Maßnahmen bei einzelnen schizophrenen Syndromen und in bestimmten krankheitsbedingten Situationen. Deutscher Universitätsverlag eBooks. https://doi.org/10.1007/978-3-322-85177-2_7
590. Ruttley, A., Ng, A., & Burnside, A. M. (2014). Medically Unexplained Symptoms and Health Anxieties: Somatic Symptom and Related Disorders. https://doi.org/10.1002/9781118560648.ch18
591. Ryall, R. W. (1989). Affective and manic depression. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511526923.013
592. Rytter, H. M. (2022). Hjernerystelse og rehabilitering af langvarige symptomer efter hjernerystelse. Psyke & Logos. https://doi.org/10.7146/pl.v42i2.131106
593. Rüstemova, D., Genç, A., Bora, G., & Tur, B. S. (2017). A thermal dysregulation problem after breast cancer surgery; what could be?. Medicine. https://doi.org/10.1097/md.0000000000007027
594. Sadiq, H., & Abakah, S. (2015). Depression and Its Relation with Blood Group According Differences (Sex).
595. Sahakian, B. J., & Morein‐Zamir, S. (2011). Depression and resilience: insights from cognitive, neuroimaging, and psychopharmacological studies. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199600434.003.0023
596. Salge, H. (2011). Dysmorphophobie. Aktuelle Dermatologie. https://doi.org/10.1055/s-0030-1256839
597. Sansone, R. A., & Sansone, L. A. (2010). Medically Unexplainable Somatic Symptoms: A Coat With Many Psychiatric Colors. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.09l00879gre
598. Santeusanio, F. (2012). Quadri internistici ed endocrinologici connessi alla disabilitŕ grave. CHILD DEVELOPMENT & DISABILITIES - SAGGI. https://doi.org/10.3280/cdd2010-003010
599. Santos, A. D. O., Soares, A. L. F., Silva, H. D. T. D., Santos, J. S. D., Silva, L. G. P. D., Silva, W. H. F. D., & Félix, P. T. (2021). Unveiling post-traumatic stress disorder: a literature review. IJS - International Journal of Sciences. https://doi.org/10.29327/229003.2.3-16
600. Santos-Franco, J. A., Santos-Ditto, R., & Revuelta-Gutiérrez, R. (2024). Neuralgia del trigémino. Actualización en Medicina de Familia. https://doi.org/10.55783/amf.200519
601. Santucci, K. T. T., Miranda, A. H., Oliveira, A. J. R., & Vieira, A. F. D. B. (2022). Psicologia organizacional e do trabalho e a humanização no contexto hospitalar. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.15
602. Sanz, G. L., Ruíz, E. C., & Vázquez, L. S. (2015). Síndrome confusional ag udo en pacientes de edad avanzada con fractura de fémur. Ágora de enfermería.
603. Sarkar, S., Singh, S. M., Balachander, S., & Rao, P. (2014). Chronic fatigue syndrome: A review. Medical Journal of Dr D Y Patil University. https://doi.org/10.4103/0975-2870.135252
604. Savani, C., Jani, M. P., & Bhatia, H. S. (2025). Koro Syndrome in Female: A Case Report of a Rare Anxiety Disorder with Cultural Influence on Psychopathology. Journal of Psychosexual Health. https://doi.org/10.1177/26318318241310662
605. Scherbaum, N., & Specka, M. (2014). Komorbide psychische Störungen bei Opiatabhängigen. Suchttherapie. https://doi.org/10.1055/s-0033-1363240
606. Schildkrout, B. (2011). Characteristics That Make Somatic Diseases Difficult to Detect. https://doi.org/10.1002/9781118083598.ch3
607. Schildkrout, B. (2011). Specific Mental Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch9
608. Schildkrout, B. (2011). Specific Physical Signs and Symptoms. https://doi.org/10.1002/9781118083598.ch7
609. Schildkrout, B. (2014). Delirium. https://doi.org/10.1002/9781394260447.ch2
610. Schildkrout, B. (2014). Disease #22: Hypersomnia, Idiopathic. https://doi.org/10.1002/9781394260447.ch50
611. Schildkrout, B. (2014). Disease #47: Parasomnias: Sleepwalking and Night Terrors. https://doi.org/10.1002/9781394260447.ch75
612. Schildkrout, B. (2014). Disease #53: Postconcussion Syndrome. https://doi.org/10.1002/9781394260447.ch81
613. Schildkrout, B. (2014). Disease #54: Premenstrual Dysphoric Disorder and Premenstrual Syndrome. https://doi.org/10.1002/9781394260447.ch82
614. Schildkrout, B. (2014). Disease #58: Restless Legs Syndrome. https://doi.org/10.1002/9781394260447.ch86
615. Schildkrout, B. (2014). Disease #61: Systemic Lupus Erythematosus. https://doi.org/10.1002/9781394260447.ch89
616. Schildkrout, B. (2014). Disease #68: Vascular Dementia. https://doi.org/10.1002/9781394260447.ch96
617. Schildkrout, B. (2014). Vegetative Symptoms. https://doi.org/10.1002/9781394260447.ch23
618. Schneiderman, N., Ironson, G., & Siegel, S. D. (2004). Stress and Health: Psychological, Behavioral, and Biological Determinants. Annual Review of Clinical Psychology. https://doi.org/10.1146/annurev.clinpsy.1.102803.144141
619. Schneier, F. R. (2003). Social anxiety disorder. BMJ. https://doi.org/10.1136/bmj.327.7414.515
620. Schneier, F. R., Bruce, L. C., & Heimberg, R. G. (2014). Social Anxiety Disorder (Social Phobia). American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg18
621. Schorb, A., Niebauer, J., Aichhorn, W., Schiepek, G., Scherr, J., & Claussen, M. (2021). Overtraining from a sports psychiatry perspective. German Journal of Sports Medicine. https://doi.org/10.5960/dzsm.2021.496
622. Schott, G. D. (2001). Delayed onset and resolution of pain: Some observations and implications. Brain. https://doi.org/10.1093/brain/124.6.1067
623. Schultz, S., North, S. W., & Shields, C. G. (2007). Schizophrenia: a review.. PubMed.
624. Schweizer, E. E., & Rickels, K. (1996). The long-term management of generalized anxiety disorder: issues and dilemmas.. PubMed.
625. Sciences, S. A. O. M. (2018). Medical-ethical guidelines: Care and treatment of people with dementia. Schweizerische medizinische Wochenschrift. https://doi.org/10.4414/smw.2018.14663
626. Scott, S., & Stone, J. (2014). iPhone-responsive functional gait disorder: Table 1. Practical Neurology. https://doi.org/10.1136/practneurol-2014-000873
627. Seifert, K. (2014). Aversive Childhood Experiences, Without Appropriate Interventions, Lead to Life Course Violent and Criminal Behavior. Journal of Psychology & Clinical Psychiatry. https://doi.org/10.15406/jpcpy.2014.01.00020
628. Sekhon, S., Patel, J., & Sapra, A. (2019). Late Onset Depression. StatPearls.
629. Seligman, L. D., Swedish, E. F., & Ollendick, T. H. (2014). Anxiety Disorders in Children. https://doi.org/10.1002/9781394259359.ch7
630. Selwood, L. (2015). Adherence in schizophrenia. Mental Health Matters.
631. Sengupta, R., Roy, S., & Bhattacharya, M. (2019). STUDY OF GENE-ENVIRONMENT CAUSES OF MAJOR DEPRESSIVE DISORDER TO STATISTICALLY DEFINE THE MOST COMMON CAUSE BEHIND IT.. International Journal of Advanced Research. https://doi.org/10.21474/ijar01/8804
632. Serelli, L. D. S. (2019). Intervenções multissensoriais aplicadas a idosos com demência moderada a avançada residentes em instituições de longa permanência..
633. Serrano, J. L., Vila, S., Vidal, R. C., Padilla, E. B., Lamora, N. S., Mollà, L., Rodríguez, A. M., & López, L. M. M. (2017). COMORBILIDAD ENTRE DEPRESIÓN Y CONDUCTAS IMPULSIVAS: UN CASO DE URGENCIA NEGATIVA.
634. Setyaningrum, D. A. W. (2019). Cedera olahraga serta penyakit terkait olahraga. Jurnal Biomedika dan Kesehatan. https://doi.org/10.18051/jbiomedkes.2019.v2.39-44
635. Shah, A., Hussain‐Shamsy, N., Strudwick, G., Sockalingam, S., Nolan, R. P., & Seto, E. (2022). Digital Health Interventions for Depression and Anxiety Among People With Chronic Conditions: Scoping Review. Journal of Medical Internet Research. https://doi.org/10.2196/38030
636. Shakhar, K., & Fleisig, D. (2013). How to Cope with Stress and Depression in Women with Recurrent Miscarriage. https://doi.org/10.1002/9781118749012.ch13
637. Shamsi, S., & Khan, S. (2019). Use of Pain Assessment Tools in Physiotherapy.
638. Sharma, S., Kishore, J., & Gupta, V. (2014). Adolescent Mental Health: From Normalcy to Illness. Indian Journal of Youth and Adolescent Health.
639. Sharpe, M. (2010). Chronic fatigue syndrome (postviral fatigue syndrome, neurasthenia, and myalgic encephalomyelitis). Oxford University Press eBooks. https://doi.org/10.1093/med/9780199204854.003.260504
640. Shear, K., Ginsberg, D., Roose, S. P., Lenze, E. J., Alexopoulos, G. S., & Hollander, E. (2005). Depression in the Elderly: The Unique Features Related to Diagnosis and Treatment. CNS Spectrums. https://doi.org/10.1017/s1092852900027176
641. Sheehan, B. (2010). Somatoform Disorders and Unexplained Physical Symptoms. https://doi.org/10.1002/9780470669600.ch102
642. Sheets, E. S., & Brosse, A. L. (2010). Major Depressive Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0522
643. Sikter, A. (2022). Chronic psychic stress can cause metabolic syndrome through mild hypercapnia.. PubMed.
644. Silva, L. M. D., Raposo-Lima, C., Soares, C. M. G., Cerqueira, J., & Morgado, P. (2016). Koro Syndrome in an Obsessive-Compulsive Disorder Patient. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.1825
645. Silva, L. M. R. (2015). A Demência Frontal: ou o Risco da Perda do Eu e do Outro. Psicologado.
646. Silva, T. D. O., Leite, J. R., Bezerra, W. D. S. P., Lima, M. B. L. D., & Fiorin, P. M. (2017). A DEPRESSÃO NA TERCEIRA IDADE:RELATO DE EXPERIÊNCIA DE UMA ATIVIDADE EDUCATIVA.
647. Silverman, M. N., & Deuster, P. A. (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus. https://doi.org/10.1098/rsfs.2014.0040
648. Sinanović, Š., Prodović, T., Martinović, B., Ratković, M., Stepić, D., Materić, T., & Sekulić, J. (2022). The role of the nurse in the assessment and treatment of pain in oncological patients. Medicinski glasnik Specijalne bolnice za bolesti štitaste žlezde i bolesti metabolizma. https://doi.org/10.5937/mgiszm2286065s
649. Singh, A., & Dubey, A. P. (2015). Role of Social Support as a Mediator in Negative Stressful Life Event and Somatic Complaints of Managerial Personnel. Indian Journal of Positive Psychology.
650. Singh, P. K. (2015). Psychogenic Headache in School Going Children. Indian Journal of Health and Wellbeing.
651. Singh, S. (2015). Mental health in infancy. International Journal of Clinical & Medical Imaging. https://doi.org/10.4172/2376-0249.1000393
652. Singh, S. K., Singh, R. K., & Singh, R. (2020). Health and psychological health in present time. Journal of Global Health Reports. https://doi.org/10.29392/001c.12225
653. Sinha, S., Moss, A. J., & Calkins, H. (2007). The etiology of sudden death. Cambridge University Press eBooks. https://doi.org/10.1017/cbo9780511544828.014
654. Sinibaldi, T. M., & Cruz-Rodrigues, C. (2022). Os efeitos da paralisia cerebral no funcionamento da memória: revisão crítica. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.16
655. Skinner, J. S. (2004). Chronic Fatigue Syndrome. The Physician and Sportsmedicine. https://doi.org/10.3810/psm.2004.02.117
656. Skokauskas, N., Pillay, D., Moran, T., & Kahn, D. (2010). Transient Auditory Hallucinations in an Adolescent. Journal of Psychiatric Practice. https://doi.org/10.1097/01.pra.0000375716.77831.ca
657. Smith, P. J., & Blumenthal, J. A. (2015). Exercise and Physical Activity in the Prevention and Treatment of Depression. Routledge eBooks. https://doi.org/10.4324/9780203132678.ch8
658. Smith, S. P. (1994). Clinical phenomena related to ‘problem patients’. https://doi.org/10.1017/cbo9780511666414.012
659. Smith, S. S. (2019). Insomnia and Clinical Sleep Disturbance in Later Life. Oxford Research Encyclopedia of Psychology. https://doi.org/10.1093/acrefore/9780190236557.013.419
660. Snaith, P. (1994). Anxiety Control Training. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.1.2.57
661. Sobel, D. S. (1995). Rethinking Medicine. Psychosomatic Medicine. https://doi.org/10.1097/00006842-199505000-00005
662. Souza, C. D., Miranda, A. H., Venturin, M. D. D. D. L., & Marino, M. F. B. (2022). Bruxismo na psicanálise, quando a dor não se cala. AYA Editora eBooks. https://doi.org/10.47573/aya.5379.2.95.9
663. Souza, S. D. (2019). SP0208 UNDERSTANDING THE IMPACT OF PAIN, SLEEP AND FATIGUE ON PATIENTS LIVES. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2019-eular.8456
664. Soyuer, F., & Kepenek-Varol, B. (2019). Quality of life and pain. International Journal of Family & Community Medicine. https://doi.org/10.15406/ijfcm.2019.03.00140
665. Spasova, R. G. (2019). ETHICAL CONSIDERATIONS IN THE INTEGRATED CARE FOR PATIENTS WITH CHRONIC PAIN. Knowledge International Journal.
666. Spence, S. A. (2006). All in the mind? The neural correlates of unexplained physical symptoms. Advances in Psychiatric Treatment. https://doi.org/10.1192/apt.12.5.349
667. Spiegel, E. P., & Vanderploeg, R. D. (2010). Postconcussion Syndrome. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0696
668. Srivastava, C., Agarwal, V., & Sitholey, P. (2019). Clinical practice guidelines for the management of somatoform disorders in children and adolescents. Indian Journal of Psychiatry. https://doi.org/10.4103/psychiatry.indianjpsychiatry_494_18
669. Stahl, S. M. (2002). Can Psychopharmacologic Treatments That Relieve Symptoms Also Prevent Disease Progression?. The Journal of Clinical Psychiatry. https://doi.org/10.4088/jcp.v63n1101
670. Stallard, P., Williams, L. S., Lenton, S., & Velleman, R. (2001). Pain in cognitively impaired, non-communicating children. Archives of Disease in Childhood. https://doi.org/10.1136/adc.85.6.460
671. Steffens, D. C., Blazer, D. G., & Beyer, J. L. (2013). Mood Disorders. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781615370016.mt05
672. Steinberg, P. (1988). Diagnostic schema for somatic and psychologic complaints.. PubMed.
673. Stevenson, I. (1969). Single Physical Symptoms as Residues of an Earlier Response to Stress. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-70-6-1231
674. Stoica, I.-P. (2021). Psychosocial rehabilitation: a myth or a legitimate field in modern psychiatry?. Psihiatru ro. https://doi.org/10.26416/psih.65.2.2021.5005
675. Stoica, I.-P. (2021). Reabilitarea psihosocială: un mit sau un domeniu legitim în psihiatria modernă?. Psihiatru ro.
676. Stone, J., Pal, S., Blackburn, D., Reuber, M., Thekkumpurath, P., & Carson, A. (2015). Functional (Psychogenic) Cognitive Disorders: A Perspective from the Neurology Clinic. Journal of Alzheimer s Disease. https://doi.org/10.3233/jad-150430
677. Stores, G., & Ramchandani, P. (1999). Sleep disorders in visually impaired children. Developmental Medicine & Child Neurology. https://doi.org/10.1017/s0012162299000766
678. Stratakis, C. A., Gold, P. W., & Chrousos, G. P. (1995). Neuroendocrinology of Stress: Implications for Growth and Development. Hormone Research. https://doi.org/10.1159/000184269
679. Stănescu, A. M. A., Simionescu, A. A., Grăjdeanu, I. V., & Florea, M. (2021). Preventive intervention for depression in children, adolescents and adults. Romanian Journal of Medical Practice. https://doi.org/10.37897/rjmp.2021.s4.13
680. Suetendael, L. V., Schrijvers, T., Broeck, K. V. D., Michielsen, J., Dom, G., & Destoop, M. (2024). [Police and judicial actors on complex mental health care needs and judicial protection measures].. PubMed.
681. Summers, C. B. (2007). Cognitive-Behavior Group Therapy in Residential Treatment. https://doi.org/10.4324/9780203941157-16
682. Suárez, A. L. Á. (2022). Evaluación del efecto antidepresivo del secretoma derivado de células madre mesenquimáticas precondicionadas en un modelo animal de trastorno depresivo mayor. https://doi.org/10.52611/11447/6617
683. Szabó, P., & Szászi, B. (2021). [Body dysmorphic disorder: One Hundred Years of Solitude].. Psychiatria Hungarica.
684. Szkodny, L. E., Jacobson, N. C., Llera, S. J., & Newman, M. G. (2014). Generalized Anxiety Disorder. American Psychiatric Publishing eBooks. https://doi.org/10.1176/appi.books.9781585625048.gg19
685. Szyguła‐Jurkiewicz, B., Szymik, M., Mrozowska, B., Schmidt, B., & Michalak, A. (2011). Psychologiczne uwarunkowania i konsekwencje ostrego zawału serca. Leki psychotropowe u chorych po ostrym zawale serca. Choroby Serca i Naczyń.
686. Tagaya, H., Murayama, N., & Hakamata, Y. (2012). [Definitions and clinical classifications of sleep disorders].. PubMed.
687. Tan, B. L. W., & Gudi, A. (2021). A rare case: Mania associated with pazopanib. Proceedings of Singapore Healthcare. https://doi.org/10.1177/20101058211023778
688. Tarn, J., Lendrem, D., McMeekin, P., Lendrem, C., Hargreaves, B., & Ng, W. (2022). Primary Sjögren's syndrome: Longitudinal real‐world, observational data on health‐related quality of life. Journal of Internal Medicine. https://doi.org/10.1111/joim.13451
689. Taylor, M. A. (1999). Bipolar Mood Disorders. https://doi.org/10.1093/oso/9780195130379.003.0008
690. Taylor, M. A. (1999). Personality And Personality Disorders. https://doi.org/10.1093/oso/9780195130379.003.0006
691. Taylor, W. D. (2014). Depression in the Elderly. New England Journal of Medicine. https://doi.org/10.1056/nejmcp1402180
692. Teasell, R., & Finestone, H. M. (1999). Socioeconomic Factors and Work Disability: Clues to Managing Chronic Pain Disorder. Pain Research and Management. https://doi.org/10.1155/1999/168470
693. Tepper, D. (2013). Cefalea Como Resultado de Conmoción Cerebral en Los Deportes. Headache The Journal of Head and Face Pain. https://doi.org/10.1111/head.12153
694. Thomas, S., Zachariah, R. A., & Mathew, N. M. (2021). Perinatal Mental Health Problems –What Midwives and Nurses can do?. International Journal of Psychiatric Nursing. https://doi.org/10.37506/ijpn.v7i1.13967
695. Thorpy, M. J., & Ahmed, I. (2008). Approach to the patient with a sleep complaint. CRC Press eBooks. https://doi.org/10.3109/9780203091715-7
696. Tollefson, G. D., Souêtre, E., Thomander, L., & Potvin, J. H. (1993). Comorbid anxious signs and symptoms in major depression. International Clinical Psychopharmacology. https://doi.org/10.1097/00004850-199300840-00013
697. Tong, G., Groom, K. N., Ward, L., & Naeem, M. Y. (2021). “This Is Not the Original Timeline”: A Case Report of an Extended Dissociative Episode in a Healthy Young Male Accompanied with Severe Decline in Mental State. Case Reports in Psychiatry. https://doi.org/10.1155/2021/6619579
698. Topinková, E. (2008). Aging, Disability and Frailty. Annals of Nutrition and Metabolism. https://doi.org/10.1159/000115340
699. Torales, J. (2018). Trastorno de síntomas somáticos: una actualización. Revista Científica Estudios e Investigaciones.
700. Torres, A. R., & Smaira, S. I. (2001). Quadro clínico do transtorno obsessivo-compulsivo. Brazilian Journal of Psychiatry. https://doi.org/10.1590/s1516-44462001000600003
701. Treanor, M., & Roemer, L. (2010). Generalized Anxiety Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0379
702. Treder, N., & Jodzio, K. (2014). Prevalence and clinical specificity of fatigue symptoms in chronic fatigue syndrome, multiple sclerosis, and myasthenia gravis. Health Psychology Report. https://doi.org/10.5114/hpr.2014.43914
703. Treede, R. (2012). Peripheral and Central Mechanisms of Neuropathic Pain. Oxford University Press eBooks. https://doi.org/10.1093/med/9780195394702.003.0002
704. Trill, M. D. (2013). Anxiety and sleep disorders in cancer patients. European Journal of Cancer Supplements. https://doi.org/10.1016/j.ejcsup.2013.07.009
705. Trimble, M. (2009). Somatoform Disorders: A Medicolegal Guide.
706. Trisnawati, S. Y., Gde, P. S. D. P., Kurniawan, L. S., Goller, A. A. C., & Dewi, V. T. (2022). GEJALA PSIKOTIK PADA PENYAKIT PARKINSON: SEBUAH LAPORAN KASUS DAN TINJAUAN PUSTAKA. Callosum Neurology. https://doi.org/10.29342/cnj.v4i2.152
707. Tso, I. F., Chun, J., & Deldin, P. J. (2010). Schizoaffective Disorder. Corsini Encyclopedia of Psychology. https://doi.org/10.1002/9780470479216.corpsy0818
708. Tuovinen, S., Lahti‐Pulkkinen, M., Girchenko, P., Heinonen, K., Lahti, J., Reynolds, R. M., Hämäläinen, E., Villa, P., Kajantie, E., Laivuori, H., & Räikkönen, K. (2020). Maternal antenatal stress and mental and behavioral disorders in their children. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2020.09.063
709. Ubaidi, B. A. A. (2017). Integrate of Spiritual Needs into Patient Care. Journal of Family Medicine and Disease Prevention. https://doi.org/10.23937/2469-5793/1510056
710. Umar, S. H., & Hermida, H. (2019). PENERAPAN KECERDASAN EMOSIONAL DALAM MENGATASI STRES SISWA DI SEKOLAH. Foramadiahi Jurnal Kajian Pendidikan dan Keislaman. https://doi.org/10.46339/foramadiahi.v10i2.119
711. Unknown (1993). Chronic Pain. Pediatrics in Review. https://doi.org/10.1542/pir.14.5.167
712. Unknown (1993). Psychosocial Risks of Chronic Health Conditions in Childhood and Adolescence. PEDIATRICS. https://doi.org/10.1542/peds.92.6.876
713. Utian, W. H. (2005). Psychosocial and socioeconomic burden of vasomotor symptoms in menopause: A comprehensive review. Health and Quality of Life Outcomes. https://doi.org/10.1186/1477-7525-3-47
714. Valeriano, J., McConnell, H., & Brillman, J. C. (1995). Prenuptial seizures: a report of five cases. Journal of Neuropsychiatry. https://doi.org/10.1176/jnp.7.1.72
715. Vallejo, J. D. O. (2001). Detecció precoç de la depressió. Revista de la Reial Acadèmia de Medicina de Catalunya.
716. Vallée, J.-P. (2010). Énurésie nocturne : informer/conseiller, évaluer, traiter. Médecine.
717. Vamsi, M., Prasad, K. S., Rajendhar, S., & Raviteja, I. (2022). Abstract- Poster. Indian Journal of Psychiatry. https://doi.org/10.4103/0019-5545.341972
718. Vanderschuren, L. J. M. J. (2008). Neurobehavioral Mechanisms of Compulsive Drug Seeking. https://doi.org/10.1093/oso/9780195300550.003.0009
719. Vanin, J. R. (2008). Brief Psychiatric History and Mental Status Examination. Humana Press eBooks. https://doi.org/10.1007/978-1-59745-263-2_2
720. Vergauwen, K. (2024). Physical activity, participation and health-related quality of life in chronic fatigue syndrome and multiple osteochondromas. https://doi.org/10.26481/dis.20240425kv
721. Vergel, J. (2022). En casa de herrero, azadón de palo. ¿Por qué estudiar medicina puede llegar a ser perjudicial para la salud y un riesgo para el fracaso académico?. Revista Ciencias de la Salud. https://doi.org/10.12804/revistas.urosario.edu.co/revsalud/a.11634
722. Viader, F. (2019). L’ictus amnésique idiopathique : un syndrome amnésique exemplaire. Revue de neuropsychologie. https://doi.org/10.3917/rne.111.0070
723. Vicente, J. F. M. (2014). Estado epiléptico refractario en el entorno de la terapia intensiva. Medicina Crítica.
724. Vidya, N. R. D., Harisoorya, A. U., Satpathy, J., & D’Mello, L. (2022). Analysis of Significant Electrocardiogram (ECG/EKG) Variations in Psychological Stress. International Journal of Health Sciences and Pharmacy. https://doi.org/10.47992/ijhsp.2581.6411.0076
725. Vilibić, M., Jukić, V., Vidović, A., & Brečić, P. (2013). Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report.. PubMed.
726. Viljoen, M., Claassen, N., & Mare, I. A. (2013). Scientific Letter: Autonomic nervous system status and responsiveness and the levels of anxiety in a normal population. African Journal of Psychiatry. https://doi.org/10.4314/ajpsy.v16i3.22
727. Villalobos, S. D., Qiu, C. H., Cordero, L. G., & Sibaja, M. C. (2022). Impacto del sedentarismo en la salud mental.. Revista Ciencia y Salud Integrando conocimientos. https://doi.org/10.34192/cienciaysalud.v6i1.404
728. Villamar, S., & Lorena, J. (2019). Factores psicosociales y depresión geriátrica en un paciente.
729. Villarroya, B. G., Voicu, A., Catalán, P. T., & Lopez, P. (2021). La soledad en el anciano, presentación de un caso clínico. Revista Sanitaria de Investigación.
730. Vlašić, K. M. (2016). Sestrinska skrb za bolesnike oboljele od depresivnog poremećaja.
731. Vliet, I. M. V. (1999). [A hidden compulsion].. PubMed.
732. Vuppalapati, C., Kedari, S., Ilapakurti, A., Kedari, S., & Shankar, J. (2019). Emotional Health: A Data Driven Approach to Understand our Emotions and Improve our Health. https://doi.org/10.1109/cse/euc.2019.00071
733. Vv, M., & Oa, L. (1999). [Mental disorders in basaloma].. PubMed.
734. Vázquez, M. S., Martínez, R. G., & Cartón, M. M. S. (2004). Alucinosis orgánica o alucinaciones visuales complejas. Síndrome de Charles Bonnet: revisión conceptual y presentación de un caso.
735. Véléa, D. (2002). L'addiction à l'exercice physique. Psychotropes. https://doi.org/10.3917/psyt.083.0039
736. Wa, D. (1985). Growth at adolescence. Clinical correlates.. PubMed.
737. Wadhwa, R., & Khandare, M. (2014). Stress Management through Yoga. Global Journal of Human-Social Science.
738. Wahyuni, A., & Berawi, K. (2016). Pengaruh Aktivitas dan Latihan Fisik terhadap Fungsi Kognitif pada Penderita Demensia. Jurnal Majority.
739. Wahyuni, A., & Fr, C. (2020). Gangguan Mental Organik e.c. Epilepsi pada Laki-Laki Usia 17 Tahun : Laporan Kasus. Jurnal Medula.
740. Wahyuningsih, S., Nurun, N., Ainul, A., Rendra, R., & Dwiki, D. (2020). Relaksasi Nafas Dalam Terhadap Tingkat Kecemasan Pada Lansia Yang Menderita Hipertensi Di RT 03 RW 09 Kelurahan Slipi Palmerah Jakarta Barat. JURNAL KREATIVITAS PENGABDIAN KEPADA MASYARAKAT (PKM). https://doi.org/10.33024/jkpm.v3i2.3194
741. Wakefield, J. C., & Schmitz, M. F. (2014). Uncomplicated depression is normal sadness, not depressive disorder: further evidence from the NESARC. World Psychiatry. https://doi.org/10.1002/wps.20155
742. Wallace, D. J., & Wallace, J. B. (2003). Fibromyalgia-Related Complaints. https://doi.org/10.1093/oso/9780195149319.003.0004
743. Wang, W., & Wang, J. (2017). Measurement of Nightmare Experience, and its Application in Research and Treatment of Psychiatric Disorders. Journal of Psychiatry. https://doi.org/10.4172/2378-5756.1000e111
744. Weel, C. V., Roberts, R., Kidd, M., & Loh, A. (2008). Mental health and primary care: family medicine has a role.. PubMed.
745. Weiner, R. (2019). Living with Chronic Pain. CRC Press eBooks. https://doi.org/10.1201/9780367810979-4
746. Welte-Santana, C., Nunes, F. T., Toledo, L. C. D., & Oliveira, L. P. (2016). Significant weight loss related to Briquet syndrome: A case report. European Psychiatry. https://doi.org/10.1016/j.eurpsy.2016.01.2084
747. Wertheimer, J. (2001). Psychiatric Treatment and Rehabilitation of the Elderly Mentally Ill. Contemporary psychiatry. https://doi.org/10.1007/978-3-642-59519-6_53
748. Wessely, S. (2001). Chronic Fatigue: Symptom and Syndrome. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-134-9_part_2-200105011-00007
749. Westenberg, H. (1998). The nature of social anxiety disorder.. PubMed.
750. Wieck, A. (2021). Risk of severe postpartum episodes. European Psychiatry. https://doi.org/10.1192/j.eurpsy.2021.202
751. Wiegant, V. M. (1991). [Stress].. PubMed.
752. Wilson, D. S., & Nutt, P. D. J. (2013). Insomnia. Oxford University Press eBooks. https://doi.org/10.1093/med/9780199674558.003.0003
753. Windt, D. V. D. (2010). The symptom of pain in populations. Oxford University Press eBooks. https://doi.org/10.1093/acprof:oso/9780199235766.003.0012
754. Winters, K. C., & Ingwalson, A. (2022). Internalizing and Related Disorders. Oxford University Press eBooks. https://doi.org/10.1093/med-psych/9780190678487.003.0006
755. Wirz‐Justice, A. (1986). [Biological rhythms and depression].. PubMed.
756. Witczak, A. (2021). Les troubles de l'accommodation liés aux médicaments.
757. Witte, L. D. D., Smits, R. B., Bartel, M., Kleijweg, M., Valk, G. D., Vinkers, C. H., & Vergeer, M. (2015). [Cushing's syndrome in a manic patient with a long-standing bipolar disorder: cause or coincidence?].. PubMed.
758. Wolkowitz, O. M. (2018). Accelerated biological aging in serious mental disorders. World Psychiatry. https://doi.org/10.1002/wps.20546
759. Wong, M. K., Darvishzadeh, A., Maler, N. A., & Bota, R. G. (2016). Five Supplements and Multiple Psychotic Symptoms: A Case Report. The Primary Care Companion For CNS Disorders. https://doi.org/10.4088/pcc.15br01856
760. Woo, C. H., & Kim, S. (2014). Effectiveness of the Military Mental Health Promotion Program. Journal of Korean Academy of Nursing. https://doi.org/10.4040/jkan.2014.44.6.717
761. Yarlagadda, A. R., Brown, A. B., & Clayton, A. H. (2007). Onset of Obstructive Sleep Apnea After Initiation of Psychotropic Agents. The Primary Care Companion to The Journal of Clinical Psychiatry. https://doi.org/10.4088/pcc.v09n0611h
762. Yennurajalingam, S., & Bruera, É. (2021). Fatigue. Oxford University Press eBooks. https://doi.org/10.1093/med/9780198821328.003.0066
763. Yohannes, A. M., & Baldwin, R. (2008). Medical Comorbidities in Late-Life Depression.
764. Yoshimasu, K., Takemura, S., Fukumoto, J., & Miyashit, K. (2012). Self-Reported Symptoms Related to Depression and Suicidal Risk. InTech eBooks. https://doi.org/10.5772/31630
765. Yutzy, S. H. (2015). Somatic Symptom and Related Disorders: Somatic Symptom Disorder, Illness Anxiety Disorder, and Conversion Disorder. Psychiatry. https://doi.org/10.1002/9781118753378.ch62
766. Zambrano, Y., & Ernesto, R. (2014). Dolor músculo-esquelético en niños.
767. Zauner, J. (1978). [Psychosomatic aspects of adolescence].. PubMed.
768. Zavala, P., & Trejo, B. D. (2009). PRESENTAR DOLOR CRÓNICO LA MAYORÍA DE LOS MEXICANOS. Gaceta UNAM (2000-2009).
769. Zawilski, Z. M. (2022). Somatisation as a manifestation of emotional disturbance in children. Pediatria i Medycyna Rodzinna. https://doi.org/10.15557/pimr.2022.0006
770. Zj, L. (1986). Somatization: a borderland between medicine and psychiatry.. PubMed.
771. Álvarez, B., Dahlitz, M., Vignau, J., & Parkes, J. D. (1992). The delayed sleep phase syndrome: clinical and investigative findings in 14 subjects.. Journal of Neurology Neurosurgery & Psychiatry. https://doi.org/10.1136/jnnp.55.8.665